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ABSTRACT
JONATHAN GELFOND:
Bayesian Model-based Methods for the Analysis of DNA Microarrays with Survival,
Genetic, and Sequence Data
(Under the direction of Dr. Joseph G. Ibrahim)
DNA microarrays measure the expression of thousands of genes or DNA fragments
simultaneously in which probes have specific complementary hybridization. Gene ex-
pression or microarray data analysis problems have a prominent role in the biostatistics,
biological sciences, and clinical medicine. The first paper proposes a method for finding
associations between the survival time of the subjects and the gene expression of tumor
microarrays. Measurement error is known to bias the estimates for survival regression
coefficients, and this method minimizes bias. The latent variable model is shown to
detect associations between potentially important genes and survival in a breast cancer
dataset that conventional models did not detect, and the method is demonstrated to
have robustness to misspecification with simulated data. The second paper considers the
Expression Quantitative Trait Loci (eQTL) detection problem. An eQTL is a genetic
locus that influences gene expression, and the major challenges with this type of data are
multiple testing and computational issues. The proposed method extends the Mixture
Over Marker (MOM) model to include a structured prior probability that accounts for
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the transcript location. The new technique exploits the fact that genetic markers are
more likely to influence transcripts that share the same location on the genome. The
third paper improves the analysis of Chromatin (Ch)-Immunoprecipitation (IP) (ChIP)
microarray data. ChIP-chip data analysis estimates the motif of specific Transcription
Factor Binding Sites (TFBSs) by comparing the IP DNA sample that is enriched for the
TFBS and a control sample of general genomic DNA. The probes on the ChIP-chip array
are uniformly spaced on the genome, and the probes that have relatively high intensity
in the IP sample will have corresponding sequences that are likely to contain the TFBS
motif. Present analytical methods use the array data to discover peaks or regions of IP
enrichment then analyze the sequences of these peaks in a separate procedure to dis-
cover the motif. The proposed model will integrate enrichment peak finding and motif
discovery through a Hidden Markov Model (HMM). Performance comparisons are made
between the proposed HMM and the previously developed methods.
iii
ACKNOWLEDGMENTS
I would especially like to thank Dr. Joseph Ibrahim for his mentorship and his
research advice during the completion of this dissertation. Also, I would like to thank
Fei Zou and Mayetri Gupta for their important contributions and guidance as well as
the other members of my committee, Fred Wright and David Threadgill. I could not
have undertaken this dissertation without the generous support of the Howard Hughes
Medical Institute Predoctoral Fellowship.
iv
TABLE OF CONTENTS
LIST OF TABLES viii
LIST OF FIGURES ix
LIST OF ABBREVIATIONS x
1 Introduction and Literature Review 1
1.1 Fundamentals of Microarrays . . . . . . . . . . . . . . . . . . . . . . . . 2
1.2 Gene Expression Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.3 Microarrays and Multiple Testing . . . . . . . . . . . . . . . . . . . . . . 6
2 Microarrays and Survival Data 16
2.1 Cancer and Gene Expression . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.2 Measurement Error Models . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.3 The Data Structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.4 The General Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.4.1 Priors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.4.2 Model Fit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.5 Case Study in Breast Cancer . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.5.1 Estimating the Measurement Error Parameters . . . . . . . . . . 38
2.5.2 Data Preprocessing . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.5.3 Results: Genes identified by the Gene Only Model . . . . . . . . . 41
2.5.4 Results: Inclusion of Clinical Covariates . . . . . . . . . . . . . . 43
2.6 Robustness Analysis and Operating Characteristics . . . . . . . . . . . . 44
2.6.1 Deviation from normality in the data . . . . . . . . . . . . . . . . 44
2.6.2 Simulations demonstrating robustness to nonnormality . . . . . . 46
2.7 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3 Microarrays and Genetics 52
3.1 Fundamentals of Genetics . . . . . . . . . . . . . . . . . . . . . . . . . . 52
v
3.2 Fundamentals of QTL Analysis . . . . . . . . . . . . . . . . . . . . . . . 54
3.3 eQTL analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
3.4 Data Structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
3.5 The Mixture Over Markers Model . . . . . . . . . . . . . . . . . . . . . 61
3.6 Extensions of the MOM model . . . . . . . . . . . . . . . . . . . . . . . . 66
3.6.1 Proximity Model . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
3.6.2 Model Fitting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
3.6.3 Calculation of the False Discovery Rate . . . . . . . . . . . . . . . 70
3.6.4 Multiple eQTL extension of the MOM model. . . . . . . . . . . . 70
3.7 Simulated Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . 72
3.8 Case Study: BXD Dataset . . . . . . . . . . . . . . . . . . . . . . . . . . 78
3.9 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
4 Microarrays for Binding Site Discovery 85
4.1 The Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
4.2 Current Methods for ChIP-Chip Data . . . . . . . . . . . . . . . . . . . . 92
4.2.1 ChIP-Chip Analysis to Identify Enriched Regions . . . . . . . . . 92
4.2.2 Sequence Analysis of Enriched Regions . . . . . . . . . . . . . . . 95
4.2.3 Motivation for a Unified Model . . . . . . . . . . . . . . . . . . . 96
4.3 The General Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
4.3.1 Probe Intensity Model . . . . . . . . . . . . . . . . . . . . . . . . 98
4.3.2 Sequence Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
4.3.3 The HMM Likelihood . . . . . . . . . . . . . . . . . . . . . . . . 101
4.3.4 Priors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
4.3.5 MCMC Fitting Procedure . . . . . . . . . . . . . . . . . . . . . . 103
4.4 Simulation Study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
4.4.1 Data Generation . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
4.4.2 Analysis of Simulated Data . . . . . . . . . . . . . . . . . . . . . 105
4.4.3 Intensity Only Model Simulations . . . . . . . . . . . . . . . . . . 107
4.4.4 Simulated Sequence Based on the TileMap Model . . . . . . . . . 109
vi
4.5 Yeast Data Case Study . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
4.5.1 Data Preprocessing and Initialization . . . . . . . . . . . . . . . . 110
4.5.2 Sensitivity Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . 115
4.5.3 Comparisons with Other Methods . . . . . . . . . . . . . . . . . . 116
4.6 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
REFERENCES 124
vii
LIST OF TABLES
1 Possible outcomes for m hypotheses . . . . . . . . . . . . . . . . . . . . . 7
2 Comparison of Significant Genes . . . . . . . . . . . . . . . . . . . . . . . 42
3 Clinical Covariates Only Comparison . . . . . . . . . . . . . . . . . . . . 43
4 Comparison of Significant Genes with Covariates . . . . . . . . . . . . . . 44
5 Operating Characteristics under True Model . . . . . . . . . . . . . . . . 48
6 Operating Characteristics under Misspecified Model . . . . . . . . . . . . 49
7 Simulated Data Parameter Estimates . . . . . . . . . . . . . . . . . . . . 77
8 Simulated Data Parameter Estimates . . . . . . . . . . . . . . . . . . . . 77
9 BXD Analysis Comparison of Parameter Estimates . . . . . . . . . . . . 79
10 BXD Analysis Comparison of Differentially Expressed Genes . . . . . . . 80
11 Different Possible Probe Outcomes . . . . . . . . . . . . . . . . . . . . . 97
12 Simulations Based on Intensity Model Enrichment Estimates . . . . . . . 108
13 Simulations Based on TileMap Enrichment Estimates . . . . . . . . . . . 110
14 Parameter Estimates from IO and IS methods . . . . . . . . . . . . . . . 117
15 Estimated Binding Site Comparisons of Four Methods . . . . . . . . . . . 118
viii
LIST OF FIGURES
1 Survival Curve for Breast Cancer Dataset . . . . . . . . . . . . . . . . . 22
2 Variance vs Mean Relationship with Model Fit Lines . . . . . . . . . . . 24
3 Trace Plots for Measurement Error Model . . . . . . . . . . . . . . . . . 40
4 Scaled Residuals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
5 Estimation of Survival Regression Parameter . . . . . . . . . . . . . . . . 47
6 Simulated Data Power Comparisons . . . . . . . . . . . . . . . . . . . . . 75
7 Simulated Data FDR Comparisons . . . . . . . . . . . . . . . . . . . . . 76
8 BXD Analysis Posterior distribution of eQTLs . . . . . . . . . . . . . . . 81
9 ChIP Process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
10 ChIP-chip Data Schematic . . . . . . . . . . . . . . . . . . . . . . . . . . 90
11 ChIP-chip Data from Rap1 Experiment . . . . . . . . . . . . . . . . . . . 91
12 Likelihood Trace Plots for Accumulating Dictionary . . . . . . . . . . . . 113
13 Selected Motif Logos of Accumulating Dictionary . . . . . . . . . . . . . 114
14 Posterior Probabilities for Probe Enrichment . . . . . . . . . . . . . . . . 119
ix
LIST OF ABBREVIATIONS
cDNA Complementary DNA
ChIP Chromatin Immunoprecipitation
DNA Deoxyribonucleic Acid
EM Expectation Maximization
FDR False Discovery Rate
HMM Hidden Markov Model
MCMC Markov Chain Monte Carlo
MLE Maximum Likelihood Estimate/Estimator
mRNA Messenger RNA
SNP Single Nucleotide Polymorphism
TFBS Transcription Factor Binding Site
x
1 Introduction and Literature Review
Microarrays are quantitative assays that can measure the gene expression levels of thou-
sands of transcripts or millions of DNA fragments simultaneously. Since the mid 1990s,
this technology has provided a wealth of new biological and medical insights from the
discovery of the often subtle influences that experimental conditions can have on gene
expression to the recognition of previously unknown cancer subtypes. In the future,
one may expect that microarrays or similar technologies will provide insights into gene
networks, and that gene expression analysis will be used to guide clinical decisions on
chemotherapy to find optimal treatments and avoid unnecessary side effects.
The scientific potential of microarrays is enormous, and the statistical challenges of the
technology are nontrivial. First, there is the problem of multiple testing. Thousands or
even millions of dependent hypotheses can be tested in a single experiment. The simple p-
values and Bonferroni corrections have been enhanced by estimates of the false discovery
rates as a means of characterizing the certainties of inferences. Second, these hypotheses
are not made independently of one another. The genes do not work independently, and
the expression measurements of the genes share parameters between them that should
be modeled in order to utilize all of the information on the array. Third, microarrays are
indirect measurements that often have several components per transcript. An estimate
of the true expression level should be obtained that summarizes these components; these
estimates are referred to as the Gene Expression Indices (GEIs). There are many other
difficulties such as normalization for experimental comparisons and outcome prediction
based on high dimensional data.
The dissertation is organized as follows. In Chapter 1, the scientific and statistical
fundamentals of microarrays are introduced. The first paper develops a measurement
error model for time-to-event data and tumor microarrays and is discussed in Chapter 2.
Chapter 3 presents the second paper and the analysis of genetics and microarrays. The
paper capitalizes on the relationship between genomic location and the genetic control
of transcription. The third paper is discussed in Chapter 4, and it concerns statistical
methods that use microarrays to discover transcription factor binding sites.
1.1 Fundamentals of Microarrays
Some biological and technological knowledge of how microarrays work is necessary for
the development and understanding of analytical methods. The biology that underlies
expression microarrays is often referred to as the “Central Dogma of Molecular Biology.”
For a review see Watson et al. (2004) or Stryer (1995). This is the principle that the
information coded in the nucleotide sequence of DNA is transcribed into mRNA which
is moved to the cytoplasm and translated into polypeptides that modulate and enzy-
matically promote most of the biochemical reactions in a cell. Gene expression is the
process of regulated transcription which is vital for cellular differentiation and function.
Microarrays are simultaneous measurements of this transcription process of thousands of
genes in a tissue or cell culture. Basically, a microarray is a snapshot quantification of
how much particular genes are being transcribed.
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There are some specifics of polynucleotide molecules like DNA and RNA that are
vital to the self-reproductive properties of cells and to microarrays. DNA molecules are
sequences of nucleotide bases that are the purines adenosine and guanine and the pyrim-
idines thymine and cytosine. In RNA, the role of the purine thymine is replaced by uracil.
The polynucleotide chains of DNA and RNA will bind according to the hydrogen bonds of
their base sequence. The pyrimidines thymine, uracil have corresponding hydrogen bonds
with the purine adenine, and cytosine has corresponding hydrogen bonds with guanine.
These favorable configurations result in the complementary binding of adenine with cy-
tosine and uracil and the binding of guanine with cytosine. Polynucleotide molecules will
preferentially bind to other nucleotides that have the complementary sequence, and this
process of one nucleotide binding to another is called hybridization. There are many va-
rieties of microarrays, but they all depend on the principle of specific hybridization. The
various mRNA of the cells are extracted through a technical process, but their sequences
remain specific to the gene from which they were transcribed in the cell. The cellular
extraction or sample of all of these mRNA is then labeled with either a fluorescent dye or
radioactive isotope that binds in a non-specific manner to the mRNA. On the microarray
slide is a spot or probe that contains the complementary sequence to a particular gene,
say “G1”. Sometimes multiple spots will represent the same gene, and these collection
of spots are called probe sets. When the sample makes contact with the slide, only the
“G1” mRNA will bind to the “G1” probes or spots because of the specific hybridization.
There may be tens of thousands of different probe sets each representing different genes
on an array. The fluorescent intensity or radioactivity of all of the probe sets can be
quantifiably measured by imaging. The resulting image of the slide is segmented into the
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different probes, and a summary statistic of the intensity of light or radiation for each
probe is obtained by image analysis (Yang et al., 2001).
Two major classes of microarrays are the two color microarrays and the Affymetrix
oligonucleotide arrays. Some of the earliest microarrays used a two dye system to obtain
a relative quantification of mRNA (Cho et al., 1997). Two different samples of mRNA
are labeled with two different fluorescent dyes (e.g. red and green) and are hybridized
to the same array. The array probes are spots containing nucleotide sequences comple-
mentary to a specific gene. The ratio of red/green of the probe’s fluorescent intensity
is taken to be a relative measure of the mRNA levels corresponding to the biological
states of the two samples. Affymetrix high-density oligonucleotide arrays are synthesized
by a proprietary photolithography process that allows the synthesis of up to 105 differ-
ent probes on the same array (Fodor et al., 1993; Lockhart et al., 1996). The probes
consist of short complementary sequences of length 25, and the probes are in perfect
match/mismatch pairs. The 13th nucleotide in a mismatch probe is not complementary
to the transcript sequence whereas the perfect match probes are entirely complementary
to the corresponding sequence. A probe set representing a gene will be about 10-20 pairs,
each complementary to a different part of the gene’s sequence.
1.2 Gene Expression Index
The Gene Expression Index (GEI) is the scalar valued summary statistic of the gene ex-
pression level based on the probe set data. For example, a probe in a two dye system has
red and green intensity components that often correspond to a control sample (green)
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and an experimental sample (red) (Pollack et al., 2002). The log-ratio of red/green
summarizes the two measurements by giving an estimate of the log of the ratio of the
concentrations in the two biological states. The motivation for using the log-ratio is man-
ifold. The ratio gives an easily interpretable comparison of the two concentrations and
may reduce variation from multiplicative noise that might be present in the measurement
variability of both the red and the green channels (Ideker et al., 2000; Rocke and Durbin,
2001). Taking the log acts to symmetrize the distribution of the ratio; the distribution of
the ratio is strictly positive and positively skewed. The log-ratio is not universal though,
sometimes the red and the green components are analyzed separately (Wolfinger et al.,
2001; Kerr et al., 2002).
In Affymetrix arrays, several different probes measure the presence of different com-
ponents of the gene’s sequence, and the models for the GEI are more complex. Early
studies used the average difference model (Lipshutz et al., 1999) as the GEI. Let P PMgij
be the intensity measurement of the gth gene’s ith measurement of the jth perfect match
probe where j = 1, . . . , J , and let PMMgij be the corresponding mismatch probe. The
statistical model has the form
P PMgij = νgj + θgi + 
PM
gij (1)
PMMgij = νgj + 
MM
gij (2)
where νgj is the common background effect, θi is the gene expression effect, and ij is the
random error. The average difference GEI is given by
ADgi =
1
J
J∑
j=1
P PMgij − P
MM
gij . (3)
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The motivation for the average difference model is the elimination of ν background vari-
ability, and the utilization of all probe data. However, there are some problems with
this model. It was seen that θgi could sometimes be negative which is problematic for
estimates proportional to concentration. Also, the average difference model did not take
into account the reduced coefficient of variation for higher values. Li and Wong (2001)
proposed a model that had parameters that reflected the various probe sensitivities to
their target. The model is as follows
P PMgij = νgj + αgjθgi + φgjθgi + 
PM
gij (4)
PMMgij = νgj + αgjθgi + 
MM
gij (5)
where φgi are the specific probe sensitivities, and αgi represent the probe sensitivities to
non-specific binding. The φgj parameter had the constraint
∑J
j=1 φ
2
gj = J . Neverthe-
less, Li and Wong showed that their model could give improved GEIs that would more
accurately detect differential expression in different biological states. Since the Li and
Wong model, there have been many competing models that give GEIs for Affymetrix
data such as Robust Microarray Analysis (Irizarry et al., 2003) and a mixed model ap-
proach of Hsieh et al. (2003). Both of these methods use a transformation of the intensity
measurements.
1.3 Microarrays and Multiple Testing
The types of hypotheses most common are those that test for the existence of an as-
sociation between a gene’s expression and the biological states of the collected sample.
For example, experiments have found associations between gene expression and cell cycle
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Table 1: Possible outcomes in testing m hypotheses
Declared Declared Total
non-significant significant
True Null U V m0
True Alternative T S m−m0
m− R R m
(Cho et al., 1997; MacAlpine and Bell, 2005), irradiation exposure (Tusher et al., 2001;
Snyder and Morgan, 2004; Burns and El-Deiry, 2003), exposure to various compounds
(Bartosiewicz et al., 2001; Lobenhofer et al., 2004; Shultz et al., 2001), and survival times
(Hastie et al., 2000; Beer et al., 2002; Vijver et al., 2002). In these studies, there are
thousands of hypotheses because there are thousands of genes. We will refer to these
hypotheses as Hi where i represents the gene identification number, and Hi = 0 when the
gene is under the null (no association), and Hi = 1 when the gene is under the alternative
(association). Classical methods generally focused on the development of testing proce-
dures that controlled the type I error rate for one or a few tests of hypotheses (Lehmann,
2005). New testing procedures were developed to increase the power of inferences in this
setting. Benjamini and Hochberg (1995) introduced the False Discovery Rate (FDR)
approach with the following Table 1.
The quantity m0
m
is the proportion of hypotheses that are truly null, and it is often
called pi0. The family-wise error rate (FWER) is defined to be
FWER = P{V > 0} = E{I[V > 0]}. (6)
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FWER is the probability that there was at least one rejection of a null hypothesis or
false discovery. If the truth concerning the m hypotheses was known such that the table
could be constructed then the FDR would be given by
FDR = I[R > 0]
V
R
= I[R > 0]
V
V + S
. (7)
Since the truth concerning these hypotheses is not known, the FDR was defined to be
FDR = E
[
V
R
|R > 0
]
P{R > 0} (8)
where V
R
= 0 when R = 0. There is a closely rated concept of the positive false discovery
rate pFDR = E[V
R
|R > 0], but for microarray analyses P{R > 0} ≈ 1 so that FDR ≈
pFDR. A simple interpretation of the FDR is the expected proportion of false discoveries
in the set that is rejected. As Ge et al. (2003) point out,
FDR ≤ pFDR ≤ FWER. (9)
The above inequality is readily shown by writing the quantities as expectations and
illustrates the utility of the FDR to avoid the excessive strictness of controlling the
FWER. Biologists and clinicians are less concerned about the probability of making a
single false discovery (FWER) than in finding a set of genes that has a FDR that is
controlled in some sense.
The FWER, FDR or pFDR may be controlled in three ways, and these three ways
depend on the conditions under which these expectations are estimated. Strong control
is achieved when these expectations are bounded from above conditional on any set of
null hypotheses being true. Exact control is a bounding of the expectations under the
condition of knowing the truth concerning the null hypotheses. Weak control is satisfied
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when the expectations are controlled under the complete null hypothesis which states
that all hypotheses are under the null. An important early result that Benjamini and
Hochberg (1995) proved for independent null hypotheses is that the FDR is controlled
in the strong sense under the following procedure. Order the p-values and let these be
P(1) ≤ P(2) ≤ · · · ≤ P(m). If one defines k to be the largest i such that P(i) ≤
i
m
q∗ and
rejects the H(r) for r ∈ {1, . . . , k}, then the FDR will be less than pi0q
∗. They do not
estimate pi0 so that they simply bound the FDR by q
∗. Benjamini and Yekutieli (2001)
extended this type of procedure to handle arbitrary dependence in the test statistics.
This procedure is as follows. If one rejects k hypotheses when k is the largest i for which
P(i) ≤
iPm
l=1 1/l
q, then the FDR is no greater than pi0q.
The Benjamini Hochberg (BH) procedure is an example of a stepwise procedure. A
stepwise procedure is one that involves using the rejection decision of other tests to in-
fluence the rejection of another. Specifically, the BH procedure is a step-up procedure
that starts at the least significant test (i.e. the largest p-value). A step-down test such as
the Westfall and Young (1993) procedure to control the FWER starts at the most signif-
icant test with the smallest p-value. These stepwise procedures are contrasted with the
single-step procedures like the Bonferroni, Sidak, minP and maxT p-value adjustments
(Ge et al., 2003). These are called single-step because the rejection decision of one test
does not involve the decisions concerning other tests.
Efron et al. (2001) and Storey (2003) utilize the connection between the FDR and
a Bayesian interpretation of the multiple testing problem. Efron et al. (2001) use an
empirical Bayes method to estimate the local false discovery rate that is the posterior
probability of a hypothesis being under the null given that it is rejected. The discussion
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of the connection between the posterior probability and the FDR will be continued later.
The pFDR may be written as Storey (2002) did
pFDR(p) = P{Hi = 0|pi < p} =
pi0P{pi < p|Hi = 0}
P{pi < p)}
(10)
with the exception that the p-value has been substituted for the test statistic. This
Bayesian construction leaves the problem of estimating the value of pi0 which Storey
does by examining the distribution of the p-values. Storey argues that in an experiment
with pi0 > 0, the density of p-values over the interval [0, 1] should become flat over some
subinterval [λ, 1]. Given a choice of λ, an estimate of pi0 is
pˆi0(λ) =
#{pi > λ}
(1− λ)m
. (11)
This estimate of pi0 is conservative (pˆi0(λ) > pi0) because some pi under the alternative
could be greater than λ. The number of rejections R(p) is taken to be a function of the
p-value cutoff. He then estimates the pFDR as
p̂FDRλ(p) =
pˆi0(λ)p
P̂ r(P ≤ p)[1− (1− p)m]
. (12)
In the above equation, the numerator pˆi0(λ)p is an estimate of the probability of the false
positive, and the denominator is the product of estimates for the probability of rejection
given p (P̂ r(P ≤ p)) and the probability that R(p) > 0 ([1− (1− p)m]). The probability
for rejection P̂ r(P ≤ p) is estimated by the observed rejection rate R(p)/m, and the
probability that R(p) > 0 is conservatively estimated under that case that the null
hypotheses are independent. Storey et al. (2004) demonstrates that his method of pFDR
estimation provides strong control when the test statistics are independent or exhibit
weak dependence. Storey et al. (2004) defines weak dependence to be the condition of
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V (p)/m0 and S(t)/(m − m0) converging almost surely as m → ∞. Weak dependence
holds for dependence in finite blocks and some other special cases, but it is not clear
that the correlation in expression data exhibits weak dependence. Specifically, there are
only a finite number of genes so that the meaning of asymptotic and continuity in the
empirical distribution cannot directly be applied.
Resampling methods like those of Yekutieli and Benjamini (1999) (YB) provide FDR
control under general dependence structure. Yekutieli and Benjamini (1999) use resam-
pling to control FDR in a similar manner as the Westfall and Young (1993) procedure
for controlling the FWER. Yekutieli correctly notes the FWER estimation through re-
sampling only requires that the null hypotheses rejected V , but FDR estimation through
resampling requires that the number of true alternatives (S) is estimated giving
FDRest(p) = EV ∗(p)
[
V ∗(p)
V ∗(p) + sˆ(p)
]
(13)
where p is the p-value threshold for significance. The YB procedure has an estimate of
S = sˆ that is negatively biased to ensure that the estimate of the FDR is conservative.
To this end, YB suggested using sˆ = mp. Reiner et al. (2003) compared the performance
in terms of power of the YB resampling method and the BH procedure. They concluded
that the YB resampling method provided small increases in power over the BH procedure.
Storey’s idea of estimating pi0 based on the density of the p-values is similar in spirit to
the Beta-Uniform Mixture (BUM) method of Pounds and Morris (2003). In this method,
the density of the p-values is modeled by a BUM given by
f(p) = λ+ (1− λ)apa−1 (14)
for p ∈ [0, 1]. They argue that an upper bound and thus a conservative estimate for pi0 is
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given by pi0 ≈ λˆ+ (1− λˆ)aˆ. The density of p-values f is written as a mixture distribution
with uniform component pi0I[p ∈ [0, 1]] corresponding to the p-values under the null
which have cumulative distribution function F0(p) = p, and the alternative component
f(p)− pi0
1− pi0
(15)
which has cumulative density Fa(p). For any p-value cutoff τ , an upper bound of the
FDR is given by
F̂DRub =
pˆi0F0(τ)
pˆi0F0(τ) + (1− pˆi0)Fa(τ)
. (16)
However, the BUM method does not model any dependence structure or address the
dependence theoretically. Broberg (2005) discusses the performance of the BUM method
as well as other methods under dependence, and found that the BUM method performs
reasonably well, but as dependence increases, the BUM method, like other methods, has
worsening performance.
There are a number of methods for estimating the FDR directly in terms of a posterior
probability. Efron et al. (2001) originally proposed the equivalence between local false
discovery rates and posterior probability, but Newton et al. (2001) developed a fully
Bayesian model for posterior probabilities involving a parametric hierarchical model for
two color microarray data. The model estimated the mixing proportion p of genes that
were differentially expressed using an Expectation Maximization (EM) (Dempster et al.,
1977) algorithm. The complete data involved an unobserved indicator variable zg that
represented whether or not transcript g was differentially expressed. They advocated
using the first-order approximation of the posterior odds
odds =
P (zg = 1|D)
P (zg = 0|D)
≈
pA(r, g)pˆ
p0(r, g)(1− pˆ)
(17)
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where pA(r, g) and p0(r, g) are the parametric densities of the red (r) and green (g)
spot intensities under the alternative (differential expression) and the null respectively.
Kendziorski et al. (2003) extended this model to include different parametric assumptions.
Kendziorski used the posterior probability in an empirical Bayes framework as a decision
rule. These parametric models were extended to a semiparametric error model by Newton
et al. (2004a). Newton proposed using the average posterior probability to estimate the
FDR and control the FDR. He defined βg to be the posterior probability of the null
hypothesis for gene g. The βg are then ranked from smallest to largest, and if βg is less
than some κ, then the genes are identified as differentially expressed. One controls the
FDR in this framework by this estimate
F̂DR(κ) =
∑
g βgI[βg ≤ κ]∑
g I[βg ≤ κ]
≤ α. (18)
Clearly, F̂DR can be controlled by choosing an appropriate κ.
Considering the FDR as an average of posterior probabilities exposes a potential
problem in some FDR procedures like Storey’s q-value. This averaging quality of the
pFDR has been proved by Efron and Tibshirani (2002). In short, the FDR is problematic
because placing a bound on the average (FDR) of a set does not bound the members of
a set (posterior probabilities). Liao et al. (2004) point out the differences between the
posterior probabilities
P{Hi = 0|pi = p} =
pi0
pi0 + (1− pi0)fa(p)
(19)
and Storey’s pFDR
P{Hi = 0|pi ≤ p} =
pi0p
pi0p+ (1− pi0)Fa(p)
(20)
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where fa and Fa are the density and the cdf under the alternative. The right hand side
in the above equation matches the FDRub in the BUM method. The difficulties with the
pFDR arise when considering inferences on specific genes. For example, it is possible
that the posterior probabilities for being under the null have a highly positively skewed
distribution, and the pFDR can be controlled but the gene of least significance could
have a posterior probabilities of being under the null equal to 0.99. Glonek and Soloman
(2003) give more examples of these poor decisions resulting in blindly controlling the
pFDR. This motivates the development of local FDR methods that approximate the
posterior probabilities such as Liao et al. (2004) and Efron (2004).
Other methods have been suggested to control the accuracy of multiple inferences
in microarray data. Versions of the negative predictive value for detecting differential
expression have been used by Liao et al. (2004) and Genovese and Wasserman (2002).
Also, Ibrahim et al. (2002) presented a parametric Bayesian model for modeling optimal
inferences concerning differential expression. This model includes correlation between the
genes as a form of dependency which was induced by the structure of the hyperparame-
ters. The ratio of the mean expression levels of different states for gene g is given by ξg.
The posterior probability γg is defined as P (ξg > 1|D), and a threshold γ0 ∈ [
1
2
, 1] is then
selected such that gene g is differentially expressed if |γg−
1
2
| ≤ γ0−
1
2
. The γ0 threshold
could then be set by using the L measure criterion. This model selection criterion was
developed by Ibrahim and Laud (1994), and it balances the posterior squared predictive
error and the posterior variance of the predictions for future observations. The optimal
model minimizes the L measure. In the gene expression model, several levels of γ0 were
assessed with the L measure and the optimal γ0 determined the list of genes declared to
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be differentially expressed. This list is approximately optimal in terms of the L measure,
and the list is determined without selecting an arbitrary p-value cutoff.
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2 Microarrays and Survival Data
2.1 Cancer and Gene Expression
The first paper presents a method for finding associations between time-to-event data
and microarrays of tumors. Microarrays have been used to study cancer in many ways.
First, scientists saw in microarrays a technique for differentiating cancer types that can-
not be differentiated by other means. Microarrays are now capable of measuring every
gene in a cell giving a near complete picture of the transcriptome. The transcriptome
contains vast amount of information about tumors and can be used to differentiate dif-
ferent types of cancer. This process of classification of high-dimensional transcriptomes
into distinct subtypes is a statistical problem known as unsupervised classification or
clustering (Hastie et al., 2001). Methods of unsupervised classification include hierar-
chical clustering (Eisen et al., 2001), self-organizing maps (Tamayo et al., 1999), and
some more statistical methods like Parmigiani et al. (2002). Microarrays are not simply
a taxonomic tool, but the transcriptome gives biological insight as well (Golub et al.,
1999). Unsupervised clustering techniques can be used to find clusters of the genes,
and biologists recognize that genes within known pathways often are found within these
clusters (Golub et al., 1999; Perou et al., 2000). The discoveries of pathways and the
gene expression patterns involved in disease is a critical component of finding targets for
potential therapies (Evans and Guy, 2004).
The transcriptomes of tumor samples have also been successfully used to predict sur-
vival for several different types of cancer including lung adenocarcinoma (Beer et al.,
2002), breast cancer (Sorlie et al., 2001; Sotiriou et al., 2003), hepatocellular carci-
noma(Lee et al., 2004), and leukemia (Chiaretti et al., 2004). The combination of survival
data and expression data has become an increasingly important and common analysis
problem. One of the fundamental difficulties in analysis of expression and survival data
is that the number of predictors (transcripts) is much larger than the number of indepen-
dent survival times. This leads to a nonidentifiability problem in estimating regression
parameters. Classical Principle Components Regression (PCR) involves using the prin-
ciple components of the data matrix as the linear predictors (Nguyen and Rocke, 2002).
The principle components with the smallest eigenvalues are discarded from analysis thus
reducing the dimension of the predictor matrix. However, Nguyen and Rocke (2002) have
shown that PCR performs poorly relative to the method of Partial Least Squares (PLS)
in predicting tumor classification based on expression profiles, but PLS is not optimal
in any reasonable way as shown by Butler and Denham (2000). The poor performance
of PCR is not surprising because principle components are an orthogonal decomposition
of the total variation of only the predictor matrix, and they are not necessarily associ-
ated with the variational patterns correlated with survival. For example, the application
of unsupervised clustering techniques to tumor data can lead to classes that are not
associated with survival as seen by Bair and Tibshirani (2004).
Several strategies have been developed for predicting survival based on expression
data, and most of them used supervised methods of classification. Supervised classifica-
tion is a technique in which the classes (here the survival data) of the objects (here the
17
transcriptomes) are known in advance of the model construction (Hastie et al., 2001).
This is contrasted to unsupervised clustering methods like those that look for previously
unknown classes in the data. Naturally, survival times are continuous and censored in
nature, so forming discrete classes is often arbitrary. If these classes are treated as known,
then the stochastic properties are ignored which can lead to overfitting (Bair and Tib-
shirani, 2004). Nevertheless, there exist many mathematical techniques for supervised
classification such as neural networks (Wei et al., 2005), support vector machines (Lee
et al., 2003), and penalized logistic regression (Shen and Tan, 2005) that have been ap-
plied to tumor gene expression. Hastie et al. (2000) developed a “gene shaving” procedure
that is related to principle components analysis and takes advantage of the survival times
in order to find clusters of genes that are associated with survival. Gene shaving accom-
plished this by selecting genes into clusters by a balance of both their associations with
survival as well as correlations with other genes. There are several tuning parameters
that must be predetermined in the gene shaving method including the balance parameter
that determines the degree to which survival data influences the principle components in
the predictor matrix. Bair and Tibshirani (2004) created a semi-supervised method for
predicting survival in which only genes most associated with survival were included in a
reduced predictor matrix. The reduced predictor matrix was then decomposed into prin-
ciple components that are used in a predictive model. It is important to notice that the
univariate associations with gene expression play a vital role in some of these supervised
methods. In the first paper of the proposal, methods are developed for improving the
joint modeling of gene expression and survival that take into account the measurement
error.
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2.2 Measurement Error Models
The measurement error of microarrays is often not modeled directly by methods that
link gene expression and survival. Ideally, one would like to consider the variability
due to microarray measurement error when making inferences because microarrays have
significant amounts of assay noise (Yang et al., 2002). The presence of noise is obvious in
the case of assay replication, but assay noise can be confounded with biological variation
depending on experimental design. In the case where the biological states are finite (i.e.
treatment and control), there is often biological and technical replication of the states.
The assay noise in the presence of biological or technical replication is accounted for
by estimating the variance within replicates in the manner of t-statistics (Dudoit et al.,
2002). No two tumors constitute the same biological state. Unless the same tumor is
assayed more than once, the assay noise will be confounded with biological variation
between tumors. The analysis of noise in the absence of either biological or technical
replication is not straightforward, but it is of interest to account for the effects of assay
noise when dealing with time-to-event data. It is a well known phenomena that failure to
account for measurement error in covariates results in asymptotic bias of the estimated
effect toward the null (Prentice, 1982; Nakamura, 1992). This gives us motivation to
develop a model that includes assay noise and avoids biased inference. Tadesse et al.
(2005) have recently shown how inferences concerning microarrays and survival can be
affected by not accounting for measurement error in Affymetrix microarrays, and we
would like to build a similar model for cDNA microarray data.
The aim of the first paper is to construct a model that accounts for the effects mea-
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surement error in cDNA microarray experiments on the assessment of associations be-
tween gene expression and time-to-event data. We present a Bayesian hierarchical latent
variable model linked with a piecewise constant proportional hazards model for the time-
to-event data. The latent variable corresponds to the Gene Expression Index, and the
hazard function is conditional upon this latent GEI. The model is shown to have favor-
able properties such as robustness to misspecification and GEIs that do not explicitly
depend on platform specific parameters. Platform specific parameters include the sensi-
tivity of the red probe compared to the green probe and the reference sample. We apply
the model to a particular breast cancer experiment that previously demonstrated novel
subtypes of breast cancer based on gene expression profiles. The time-to-event of interest
is time-to-death due to disease.
Characterizing the association between time-to-event data and gene expression is
similar to the differential expression problem because event data constitutes a biological
state, although the state is complex in that the state space is censored and infinite. The
broader problem of differential expression requires that the gene expression for a partic-
ular gene on an array is measured or computed. The aforementioned value of a gene’s
expression is often referred to as the gene expression index (GEI) (Li and Wong, 2001).
The GEI is computed in numerous ways depending on the type of array and the model
used. The probes or spots on an individual array have complementary subsequences
highly specific to the corresponding gene’s RNA in the samples. The proposed model
extends the additive error-in-variable survival model for Affymetrix data of Tadesse et al.
(2005) to two color microarrays with correlated multiplicative errors. The error model
is included within the framework of a piecewise exponential survival model. Robustness
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analyses are performed, and the model is applied to a breast cancer study dataset.
2.3 The Data Structure
The data analyzed were obtained from experiments performed on breast cancer samples
with similar types of cDNA microarrays. There were a total of 85 microarrays of tumor
(78), normal tissue (4), and other tissue (3) from 84 individuals, but clinical information
was available from only 77 of the individuals who corresponded to tumors. Of these 77
individuals, 75 had time-to-event data available. This subset of the data is the focus of
the paper. There were six batches of microarrays, some arrays having 24k probes and
others having 8k probes. A common subset of 7,938 probes were selected. In the green
channel, one of three batches of standardized reference were used. The red channel for
each array consisted of the 75 tumor samples. It has been reported that the differences in
the array type and the batch effect due to reference add some variability to the analysis
(Sorlie et al., 2001), but this noise is not considered here. The dataset is available from
the Stanford Microarray Database (http://genome-www.stanford.edu/microarray) . The
endpoint studied was time to death due to disease in months. Survival times were between
0 and 100 months (mean 35.43, median 30.0). Twenty-six of the 75 patients experienced
the event after time 0, A Kaplan-Meier curve of the 75 patients is shown in Figure 1.
2.4 The General Model
The goal is to characterize the association between gene expression of particular genes
and time-to-event data. The model proposed will integrate both survival times and a
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measurement error model. The data is inherently trivariate in that the red and green
channels of any probe are potentially correlated with survival and jointly modeled. Some
notation will be introduced for this two color data. Each spot on the array will be
described as Pgir which are vectors of length two whose indices g, i and r refer to the g
th
gene and the ith individual at the rth replicate respectively. The elements of Pgir are Rgir
and Ggir which are the red and green fluorescent measurements of the spot. Pgir may be
written as Probegir ≡ Pgir =
 Rgir
Ggir
.
The measurement error model is adapted from one proposed by Ideker et al. (2000).
Ideker’s model consists of a bivariate normal error with an additive component and a
multiplicative component. The multiplicative component will be called the spot effect
(spot ≡ S). The spot effect is the motivation for taking the ratio of Rgir/Ggir. By
dividing R by G, the general assumption is that the multiplicative error will cancel.
The additive component is related to the background effect (B). An examination of the
data reveals the relationship between the mean probe intensity and the variance of the
probe. Figure 2 shows the log of the sample variance plotted against log of the sample
mean in the green and red channels of our dataset. There appears to be a strong linear
relationship between log(probe mean) and log(probe variance).
Stating the model in equation form we have
Pgir = MgiSgir +Bgir, (21)
where
Sgir ∼ N2

 1
1
 ,
 σ2mR ρmσmRσmG
ρmσmRσmG σ
2
mG

 ,
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Bgir ∼ N2

 0
0
 ,
 σ2aR ρaσaRσaG
ρaσaRσaG σ
2
aG

 ,
and
Mgi =
 µRgi 0
0 µGgi
 .
The diagonal elements of Mgi are interpreted as the mean intensities for gene g and state
i since E[Pgir] = [µRgi µGgi]
′, and this is what motivates the mean vector of
 1
1
 for
Sgir. The covariance parameters for the multiplicative error are σ
2
mR, σ
2
mG, and ρm which
represent the variability due to a multiplicative effect in assay replication of biologically
identical samples. Similarly, the covariance parameters for the additive variability due
to replication are σ2aR, σ
2
aG, and ρa.
There are other models for cDNA data with both additive and multiplicative compo-
nents. Rocke and Durbin (2001) suggest a log-normal multiplicative error with a normal
additive error. This model presents major computational challenges because Pgir does
not have a standard distribution, and the likelihood cannot be written in closed form.
Rocke and Durbin (2001) suggest an iterative fitting procedure on different subsets of
genes for the additive and the multiplicative components separately. However, we do not
choose this model for three reasons. First, analysis of the residuals of the log transformed
data suggest that the log-transformation over-corrects for the relatively small amount of
skewness in the data. Second, the difficulty of dealing with a nonstandard distribution
adds to an already heavy computational burden. Third, we show in Section 2.6 that the
estimation of survival parameters and GEI’s with a model based on a normality assump-
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tion are robust to this type of misspecification of the multiplicative error distribution.
However, even the Ideker model is not identifiable unless there is technical replication
in both the red and green channels. In the dataset considered in this paper, we do not
have such replication except in a small number of duplicate probes on each array (about
180). An analysis of these probe measurements was performed on the green and the red
channels separately, and the estimates of σ2mR and σ
2
mG were found to be approximately
equal. With this justification, we set the constraint σ2mR = σ
2
mG = σ
2
m for the purpose
of model identifiability. Also, the variance parameters due to the additive components
(σ2aR, σ
2
aG, and ρa) were found to be very small relative to the multiplicative error, so we
set them to zero. The parameters µRgi and µGgi are the means within a biological state.
When a common reference is used, µGgi becomes µGg and it represents the mean intensity
of the reference channel, and µRgi is the mean of the sample channel. In experiments
with biological replication within a channel, the means of the intensities measured are
often considered to be derived from the same underlying population, so that µRgi = µRg
for replicates within a biological state. We must account for the biological variability in
tumor samples, and thus we consider an additional hierarchical component to the model
and take µRgi = µRg(1 + βgi) The parameter βgi is the latent GEI and represents the i
th
tumor’s and the gth gene’s deviation from mean of that gene (µRg). βgi is taken to be a
truncated normal variable with βgi > −1 because βgi + 1 is considered to be proportional
to a concentration, and therefore, βgi + 1 must be positive. The method of identifying
the GEI as a latent variable is novel. It is well suited for tumor samples because it gives
a structure to the variation in a gene’s expression. The structure of the truncated normal
distribution acts to resist outlying measurements so that the GEI’s have a regression to
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the mean. The model can be restated in another equivalent form.
Rgi = µRg(1 + βgi)Rgi (22)
Ggi = µGgGgi (23)
where
Sgi ≡
 Rgi
Ggi
 ∼

 1
1
 ,
 σ2m ρmσ2m
ρmσ
2
m σ
2
m


and
βgi ∼ N{βgi>−1}(0, σ
2
bio).
We have a simple physical model that assumes that the intensity of a probe (P ) is roughly
proportional to product of the concentration ([mRNA]) of the target mRNA in the sample
and the sensitivity of the probe (φ). In equation form we have P ≈ [mRNA] × φ. The
physical model is motivated in part because of the Li and Wong model for Affymetrix
data which takes the following form for a single gene:
Pij = νj + θiφj + ij (24)
Here, Pij represents the i
th measurement jth probe with sensitivity φj and background
νj. θi is the gene expression index and ij is a normally distributed error term. The
difference between our model and models like that of Li and Wong is that the GEI of
individual i is not a random effect. That is, in the Li and Wong model, the biological
variation of GEI’s is not modeled explicitly. We extend the form of the Li and Wong
model to cDNA data here for the case of a standard reference in the green channel by
taking
Pgir = ΘgiΦgSgir, (25)
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where Φg =
 φRg 0
0 φGg
 and Θgir =
 [red]gi 0
0 [green]g
.
The parameters φRg and φGg are the platform specific sensitivities of the red and
green channels respectively. The Θgi denotes a matrix whose diagonal elements [red]gi
and [green]g are the concentrations of RNA on the specified array. This model statement
is consistent with (21) if we let ΘgiΦg = Mgi and set Bgi = 0. The problem of gene by
dye interaction occurs for some genes when the intensity of the red channel and the green
channel respond differently to the same concentration gradient. Using the language of
this model, gene by dye interaction can be stated as φRg 6= φGg. The connection with
this model and the log-ratio can be seen by considering the special case that ρm = 1.
The log-ratio is given by
ψgir ≡ log(Rgir/Ggir) = log ((φRg/φGg)([red]gi/[green]g)) . (26)
The three deficiencies of ψgir can be noticed. First, if the values in the red or green channel
are negative, then the log-ratio cannot be computed, and this generates missing data
despite the clear informativeness of low values. Second, the platform specific parameters
of φRg and φGg are contained in the GEI. Third, the reference specific parameter µGg is
also affecting the GEI, and these two problems complicate the interpretation and the cross
platform comparisons of the log-ratio. Now, consider the parameter βgi. The parameter
can be stated in terms of the ratio of intensity parameters as βgi = (µRgi/µRg) − 1.
According model 29, µRgi = φRg[red]gi and µRg = φRg[redg] then,
βgi = (µRgi/µRg)− 1 = ([redgi]/[red]g)− 1. (27)
Thus, βgi does not explicitly depend on platform or reference specific parameters for
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the reason that it is a function of the ratio of the mean intensities, and that ratio is not
dependent on the probe sensitivity or the reference channel.
The parameter βgi will also be linked to the following piecewise constant hazards
survival model. This model divides the survival time axis into J adjacent disjoint intervals
(s0, s1], (s1, s2], ..., (sJ−1, sJ ] where 0 = s0 < sj < sj′ if (0 < j < j
′) and j = 1, . . . J .
Within each interval is a constant baseline hazard h0(y) = λj when y ∈ (sj−1, sj]. We let
νi = 1 be the failure indicator for the i
th individual (νi = 0 otherwise), and let δij = 1
if the ith individual was either censored or failed in the jth interval (δij = 0 otherwise).
The survival component contribution of the likelihood for the ith individual becomes
f(yi|βgi, γc) =
J∏
j=1
(λjexp(ηi))
δijνiexp{−δij
[
λj(yi − sj−1) +
j−1∑
k=1
λk(sk − sk−1)
]
exp(ηi)}
(28)
where ηi = log(βgi + 1)γg + Z
′
iγc is the linear predictor. Zi is the p× 1 vector of clinical
covariates for the ith individual, and γc is the corresponding p× 1 vector of coefficients.
Note that βgi has been log transformed for comparisons with the log-ratio models.
In this paper, we consider only one gene’s (g = g′) association with survival at a time
so βg′ refers to the vector of latent GEI’s for the g
′(th) gene, but P refers to all probe
data, that is all of the red and green channel measurements. The model parameters are
Ω = {λj, βg′i, γ
′
g, γck, µRg, µGg, σm, ρm, σBg}.
The dataset consists of D = {Pgi, Y, νi, δij, }. The full likelihood function is the given
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by
L(Ω|D) ∝
n∏
i=1
G∏
g=1
φ2
Pgi;
 µRg(1 + βgi)
µGg
 ,
 µ2Rgiσ2m ρmσ2mµRgiµGg
ρmσ
2
mµRgiµGg µ
2
Ggσ
2
m


× φ{βgi>−1}(βgi; 0, σ
2
Bg)
×
J∏
j=1
[
λje
(log(βg′i+1)γg′+Ziγc)δijνi
]I[g=g′]
×
[
exp{−δij
[
λj(yi − sj−1) +
j−1∑
k=1
λk(sk − sk−1)
]
elog(βg′i+1)γg′+Ziγc}
]I[g=g′]
. (29)
where φ2() is the bivariate normal density, and φ{βgi>−1}() is the left truncated normal
density. Again, ηi = log(βg′i + 1)γg′ + Ziγc is the linear predictor for survival involving
only one gene (g′). Also, µgRi = µgR(1 + βgi) for convenience.
The likelihood has two parts. The first part will pertain to the measurement error
model, and the second part is the survival model. This dichotomy of the likelihood
motivates the two stage fitting procedure described in Section 2.4.2.
2.4.1 Priors
Bayesian models involve the specification of priors as well as the likelihood, therefore
the specification of priors will complete our model. We do not have information about
parameters from previous studies, and therefore we choose priors that are relatively non-
informative or vague. We use the following priors for the parameters
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µ−1Rg|µi, σ
2
µi
∼ N{µRg>0}(µim
−1
Rg , σ
2
µi
m−2Rg) [mRg =
1
ng
ng∑
i=1
Rgi] (30)
µ−1Gg|µi, σ
2
µi
∼ N{µGg>0}(µim
−1
Gg, σ
2
µi
m−2Gg) [mGg =
1
ng
ng∑
i=1
Ggi] (31)
σ−2m |αm, ωm ∼ gamma(αm, ωm) (32)
ρm ∼ Unif(0, 1) (33)
σBg|αB, ωB ∼ gamma(αB, ωB) (34)
λj|α0, ω0 ∼ gamma(α0, ω0/λj−1)(λ0 = 1) (35)
γg′|σ
2
g ∼ N(0, σ
2
gene) (36)
(37)
The gamma priors on the λj’s are chosen because they are strictly positive, conju-
gate, and they induce correlation between adjacent λ′s. Such correlated priors create
smoothness in the baseline hazard and were introduced by Arjas and Gasbarra (1994).
Such correlated priors are also discussed in Ibrahim et al. (2001). The prior for σBg
was chosen to be a vague gamma prior; the prior was taken for on σBg instead of the
precision parameter σ−2Bg because the former is more easily interpreted, and the precision
parameter of a truncated normal does not have a conjugate gamma prior. The prior for
σ−2m is a vague gamma prior because this is the conjugate form. A vague normal prior
was selected for the survival coefficients γg and to let the likelihood drive the inference
and make the survival parameters comparable to the Cox model for comparison. The
µ parameters in both models had priors that cover the range of the measurements, and
a vague prior is placed on µ−1Gg and µ
−1
Rg instead of the reciprocal to take advantage of
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the log-concave posterior which facilitates a more efficient Gibbs sampling scheme. See
the appendix for computational details. The array data is scaled to avoid numerical
problems. This scaling by mGg and mRg results in the choice of µi = 1.
2.4.2 Model Fit
Our goal is to fit the model (29) on a gene by gene basis in a computationally effi-
cient manner, and the parameter of interest is γg′ because γg′ determines the association
between gene expression and time-to-event. We could fit the full model likelihood for
each gene, but doing so would be computationally expensive because parameters such as
(βgi, µgR, andµgG) relating to other genes would then be estimated as well. The number
of these nuisance parameters is on the order of n ∗ G ≈ 100, 000. To facilitate a more
feasible fitting scheme, the model was fit using an MCMC method in two stages. These
two stages correspond to the two parts of the likelihood. In the full likelihood, the first
part contains information about the measurement error parameters (σm, ρm, σBg) for all
genes, and the second part contains the parameters of the survival model. One may
notice that the measurement error parameters are shared across all genes and that one
individual gene’s contribution to the likelihood should be relatively small. Further, our
analysis has shown that these parameters can be estimated to a reasonably high precision
by using a large number of genes (≥ 500). Thus, in the first stage of the model fitting,
we will estimate the measurement error parameters using likelihood
 L(Ω|D) =
n∏
i=1
G∏
g=1
φ2
Pgi;
 µRg(1 + βgi)
µgG
 ,
 µ2Rgiσ2m ρmσ2mµRgiµGg
ρmσ
2
mµRgiµGg µ
2
Ggσ
2
m

(38)
× φ{βgi>−1}(βgi; 0, σ
2
B)
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The biological variance parameter σB is chosen in this stage to be the same for each
gene for computational convenience and to borrow strength across genes. Alternatively,
one could select of subset of housekeeping genes thought to have the same low biological
variability, and use only these genes to estimate the measurement error parameters. From
this model fit, we will use the estimates of the measurement error parameters σˆm and ρˆm
and substitute them into (29) and this will constitute the second stage of the model fit:
L(Ω|D) ∝
n∏
i=1
φ2
Pgi;
 µRg(1 + βgi)
µg′G
 ,
 µ2Rgiσˆ2m ρˆmσˆ2mµRgiµGg
ρˆmσˆ
2
mµRgiµGg µ
2
Ggσˆ
2
m

φ{βg′i>−1}(βg′i; 0, σ2Bg′)
×
J∏
j=1
(λjexp(ηi))
δijνiexp{−δij
[
λj(yi − sj−1) +
j−1∑
k=1
λk(sk − sk−1)
]
exp(ηi)}. (39)
The second stage will be applied to each gene, and the parameters associated with the
measurement error (σˆm, ρˆm) remain fixed. Further, we found that the model is weakly
identifiable when σB becomes large (σB > 2). For large σB, the parameters σB and µRg
become confounded. So, for the second stage of the analysis, we fixed µRg =
1
n
∑n
i=1Rgi.
We found that this constraint only had slight influence on the inferences regarding the
parameter of interest (γg). In order to classify the genes as either significantly associated
with an survival or not, we will use the highest posterior density (HPD) intervals for
the γg parameter. If and only if the interval does not contain 0, then the gene will be
included in the list of genes associated with survival.
We fit the models using a Gibbs sampling technique in which samples from the joint
posterior (L(D|Ω)pi(Ω)) are obtained by successively sampling from the full conditionals
for a number of iterations after convergence criteria are met. The log likelihood functions
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of the full conditionals for the first stage of the model fit are given below: For notational
convenience let
SSR =
G∑
g=1
ng∑
i=1
(Rgi − µRg(1 + βgi))
2
(µRg(1 + βgi))2
,
SSG =
G∑
g=1
ng∑
i=1
(Ggi − µGg)
2
µ2Gg
,
SRG =
G∑
g=1
ng∑
i=1
(Rgi − µRg(1 + βgi))(Ggi − µGg)
µGgµRg(1 + βgi)
,
mRg =
1
ng
ng∑
i=1
Rgi , and
mGg =
1
ng
ng∑
i=1
Ggi .
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We have
p(µ−1Gg|rest) ∝ exp{−
1
2σ2m(1− ρ
2
m)
[
1
µ2Gg
ng∑
i=1
G2gi
−
2
µGg
ng∑
i=1
(
Ggi + ρm
(
RgiGgi
µRg(1 + βgi)
−Ggi
))
]}
× µ
−ng
Gg exp
{
−
(µ−1Gg − µim
−1
Gg)
2
2σ2µim
−2
Gg
}
I [µGg > 0] ,
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1
2σ2m(1− ρm)
[
1
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i=1
(
Rgi
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)2
−
2
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+
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(
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−
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2
2σ2µim
−2
Rg
}
I [µRg > 0] ,
p(σ−2m |rest) ∼ gamma
(
αm +
G∑
g=1
ng, ωm +
1
2(1− ρ2m)
[SSR + SSG − 2ρmSRG]
)
,
p(ρm|rest) ∝ exp
{
−
1
2
G∑
g=1
ng log(1− ρ
2
m)−
1
2σ2m(1− ρ
2
m)
(SSR + SSG − 2ρmSRG)
}
× I [ρm ∈ [0, 1]] ,
p(βgi|rest) ∝ exp{−
1
2σ2m(1− ρ
2
m)
[
(Rgi − µRg(1 + βgi))
2
(µRg(1 + βgi))2
− 2ρm
(Rgi − µRg(1 + βgi))(Ggi − µGg)
µGgµRg(1 + βgi)
]}
× (1 + βgi)
−1 exp
{
−
β2gi
2σ2B
}
I [βgi > −1] , and
σB|rest ∝ (1− Φ(
−1
σB
))−
PG
g=1 nGσ
−
PG
g=1 ng+αB
B exp
{
−ωB −
1
2σ2B
G∑
g=1
ng∑
i=1
β2gi
}
.
where ”rest” denotes the data and the remaining parameters.
Computation for the Gibbs sampler was performed using the C language. The full
conditionals of ρm, σm, and βgi were sampled using the Adaptive Rejection with Metropo-
lis Sampling (ARMS) algorithm of Gilks et al. (1995). The µ−1 parameters have a log-
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concave density, and could be sampled directly using Adaptive Rejection Sampling (ARS)
(Gilks and Wild, 1992). The parameter σ−2m has a gamma distribution which could be
sampled using standard statistical algorithms. The ordered overrelaxation technique of
Neal (2003) was used when sampling from the σ−2m , µ
−1
Rg and µ
−1
Gg full conditionals to
reduce autocorrelation of the Gibbs sampler and improve convergence.
The second stage of the model fit has additional parameters relating to the survival
model, and it treats the measurement error parameters σm and ρm as known by substi-
tuting in their estimated values from stage 1. Further, the parameter µRg set to mRg
(defined above) for identifiability. Below are the full conditionals for the second stage of
the model. For notational convenience, we define Λi as the cumulative baseline hazard
for individual i
Λi =
J∑
j=1
δij
[
λj(yi − sj−1) +
j−1∑
h=1
λh(sh − sh−1)
]
.
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We now have
p(µ−1Gg|rest) ∝ exp{−
1
2σ2m(1− ρ
2
m)
[
1
µ2Gg
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G2gi
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]}
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−
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2
2σ2µ0
}
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2
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−1
σB
))−ngσ
−ng+αB
B exp
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−ωB −
1
2σ2B
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i=1
β2gi
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,
p(γg|rest) ∝ exp
[
n∑
i=1
γgνiβgi − Λie
log(βgi+1)γg′+Z
′
iγc
]
× exp
[
−
1
σ2g
γg
]
,
p(γck|rest) ∝ exp
[
n∑
i=1
γckνiZik − Λie
log(βgi+1)γg′+Z
′
iγc
]
× exp
[
−
1
σ2c
γck
]
, and
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(
α0 +
n∑
i=1
νiδij,
ωo
λj−1
+
n∑
i=1
∆ije
log(βgi+1)γg′+Z
′
iγc
)
where ∆ij = (min(yi, sj)− sj−1)
+.
Again, the ARMS algorithm was used to sample from the posterior distribution within
the Gibbs framework for the all of the parameters except λj. The γck and γg parameters
have full conditionals that are log-concave so that the ARS algorithm is potentially
applicable; however, numerical imprecision sometimes yielded non-concave log-likelihood
functions despite the analytical log-concavity of the conditionals. Since ARMS is a more
general sampling method, it was used for these parameters. Also, within the ARMS
algorithm, the value of the log-likelihood function of the parameters γg and βgi was
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truncated in the extreme tails to avoid numerical imprecision. Again overrelaxation was
used for the µGg parameter to improve convergence properties.
2.5 Case Study in Breast Cancer
We use the model in the previous section to examine the breast cancer data described
in Section 2.3. As mentioned above, the model was in two stages, measurement error
parameter estimation and survival analysis.
2.5.1 Estimating the Measurement Error Parameters
We normalized the microarrays before applying our model. There are many normalization
procedures available for cDNA (Yang et al., 2002). However, most of these methods are
applied to the log-ratio as opposed to the red and green channel individually. For our
purposes, we jointly model the red and green channel instead of modeling log(R/G).
Moreover, there is no replication of samples that is an important component of many
normalization procedures. For normalization, we choose to perform a simple scaling
procedure as follows. One array without major problems such as poor green or red dye
measurements is chosen as the standard, and the red channel measurements from that
array are scaled so that the mean of the red channel is equal to the mean of the green
channel. Then, all other arrays are scaled so that the means of each channel’s probes are
equal to the mean of the green channel of the first array. This method was chosen above
quantile normalization because it better preserved the correlation between the red and
the green channels across arrays. When we compare our method to one that uses the
log-ratio, we used the log-ratio normalization procedure used by (Sorlie et al., 2001).
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After the arrays were normalized, we estimated the measurement error parameters by
sampling 500 probes at random from the original 7,938 probes. Prior parameters were
selected as follows: (αB, ωB) = (2, 0.1); (αm, ωm) = (2, 0.1); (µi, σ
2
µi
) = (1, 100). The
burn-in period of 10,000 Gibbs sample was used to achieve convergence, and the number
of samples used was 50,000. The convergence of the Gibbs sampler was diagnosed with
parallel chains by using the Gelman and Rubin
√
Rˆ statistic (Gelman and Rubin, 1992).
Convergence diagnostics were computed with the R coda package (Plummer et al., 2005).
See the Figure 3 for trace plots.
There was some autocorrelation in the parameters that slowed convergence, but the
effect on parameter estimation was small as the mean of the posterior estimates were
within 1% of their final estimates very early in the chain (i.e. after a few hundred
iterations). The measurement error model then yielded estimates for these parameters
as follows: σB = 0.5752(0.0062); σm = 0.6082(0.0029); ρm = 0.9347(0.0021).
These parameters suggest a large amount of variation due to assay noise. The coef-
ficient of variation due to the multiplicative technical error is σˆm, and the correlation of
the red and green components of this multiplicative effect is ρˆm which suggests that the
log-ratio has significant error. These parameters will now be considered fixed in the gene
by gene survival analysis stage.
2.5.2 Data Preprocessing
Before survival models are fitted, there is some data preprocessing including gene filtering
and imputation of missing data. The large number of genes relative to the number of
independent observations makes it beneficial to limit the analysis to a subset of probes
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Figure 3: Trace plots of select parameters (σB, σm, and ρm) of measurement
error model with lag 1 autocorrelation
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that meet some threshold of variability across samples. We used a similar inclusion
threshold to that of the original analysis. We considered only probes that had at least
3 samples that were a 4-fold change from the median log-ratio. From that list, we took
a subset of those probes which had missing data in the green or red channels for no
more than 10 out of the 75 arrays. This left 991 probes for examination, but there
were duplicated gene names in the probe list. All duplicate gene names were removed
for the survival analysis which left 942 genes. The missing data in the reduced set
was then imputed using the log-ratio. Specifically, imputation was performed using
the Statistical Analysis for Microarrays package (Tusher et al., 2001) with a K-nearest
neighbor algorithm in which K=10.
2.5.3 Results: Genes identified by the Gene Only Model
Our goal is to find a list of genes that are associated with time-to-event in breast cancer.
We perform two types of analyses and compare the results with a conventional Cox pro-
portional hazards model. The analysis presented here tests the gene’s survival association
without additional clinical covariates. For comparison, we fit a Cox proportional hazards
model with standard software R Development Core Team (2004a) using the log-ratio as
the GEI covariate. When constructing gene lists using the Cox model, the p-value of the
corresponding regression parameter was used to determine association. Specifically, lists
with genes having a p-value cutoff of < 0.01 for the regression parameter will be com-
pared to lists including genes whose γg parameters have 99% HPDs that do not contain
0. The latent variable and the Cox models were fit to the 942 genes. The prior hyperpa-
rameters for the survival model are as follows: (αB, ωB) = (2, 0.1); (α0, ω0) = (0.01, 0.01);
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(µi, σ
2
µi
) = (1, 100); σ2gene = 100.
The Gelman-Rubin statistic was again used to assess convergence, but because of the
number of models (942), convergence could not be thoroughly examined except for a
few genes. Based on these models, a conservative estimate for the number of iterations
needed to achieve convergence was used for all genes. A burn-in of 5,000 cycles, and
10,000 samples were used to summarize the posterior estimates. The results compare
lists of genes selected to have a significant association with survival by the by proposed
model and the Cox model given in Table 2.
Table 2: Comparison of significant gene lists for Gene Only Model
Proposed Model
Significant Not Significant Total
Cox Significant 65 18 83
Model Not Significant 13 846 859
Total 78 864 942
There is significant agreement between the the two lists. For the sake of brevity, we
will focus a few important genes. The intersection of the two lists includes genes which
have known associations with breast cancer such as the estrogen receptor Perou et al.
(2000), gamma glutamyl hydrolase (Rhee et al., 1993), and the angiotensin receptor 1
(AGTR1) gene (De Paepe et al., 2001). Of the 13 genes that were detected by the
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Table 3: Clinical Covariates Only Comparison
Cox Model Piecewise Exponential
Covariate Estimate (SD) Estimate (SD)
Age 0.049 (0.259) 0.014 (0.274)
Tumor Category 0.606 (0.267) 0.640 (0.269)
Grade 0.488 (0.230) 0.483 (0.234)
ER status 0.747 (0.202) 0.726 (0.205)
proposed model only, we have found that some of them have associations with breast
cancer such as estrogen regulated LIV-1 protein (Dressman et al., 2001) and the 5T4
oncofetal trophoblast glycoprotein gene (Kopreski et al., 2001).
2.5.4 Results: Inclusion of Clinical Covariates
The clinical covariates of age (< 40), tumor category (1,2,3,4), grade (High, low), and
ER status (+/-) were entered into the model. Tumor category corresponds to the size
of the tumor, so it was treated as a continuous covariate instead of a factor. First, the
clinical covariates were fit without the expression data in order to compare the Cox and
the piecewise exponential models. All of these clinical variables were centered and scaled.
A burn-in period of 5,000 samples were taken and 10,000 samples were used to compute
the posterior estimates. The results in Table 3 show the close agreement between the
two models.
The results of the model fit with these covariates and each of the genes are shown in
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Table 4. A burn-in of 7,500 cycles and 10,000 samples were used.
Table 4: Comparison of significant gene lists with covariates
Proposed Model
Significant Not Significant Total
Cox Significant 19 11 30
Model Not Significant 8 904 912
Total 27 915 942
Many of the 19 genes selected by both models have associations with breast cancer
such as Claudin 4 Kominsky et al. (2004). Some of the 8 genes selected only by the
latent variable model have associations with breast cancer in the literature such as the
somatomedin gene (Byron et al., 2006).
2.6 Robustness Analysis and Operating Characteristics
2.6.1 Deviation from normality in the data
According to the model, the array data in the green channel for a particular probe is
normally distributed about the same mean so that greengi ∼ N(µGg, µ
2
Ggσ
2
m). One may
calculate the scaled residuals in a typical manner of subtracting the sample mean and
then dividing by the sample standard deviation for each gene. To examine the validity
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of the distributional assumption, we show a histogram of the scaled residuals in Figure
4. The normal density is overlaid.
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Figure 4: Scaled Residuals with normal density curve.
One can detect that the distribution is skewed to the right with a heavier tail. One
could consider a transformation, but transformations dilute the relationship between the
mean and the variance. The distribution of the red channel is much more complicated
under the model because it is the product of a normal and a truncated normal random
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variable.
2.6.2 Simulations demonstrating robustness to nonnormality
In order to characterize the effects of this deviation from normality, we performed a
robustness analysis with a simulation. We used the log-normal model of Rocke and
Durbin (2001) without the normal additive error to simulate a dataset and applied our
two stage model fitting procedure to 200 different datasets with n = 75 individuals. The
true measurement error parameters of the simulation were σm = 0.6, ρm = 0.9, and
σBg = 0.5. A total of 500 genes were simulated with µgR = |Xgi| and µgG = µgRYgi
where Xgi ∼ N(10, 000, 3, 000) and Ygi ∼ gamma(2, 2). The estimates (and SD’s) from
the model fit were (σˆm = 0.651 (0.005), ρˆm = 0.985 (0.001), and σˆBg = 0.59 (0.05)).
Then, 200 survival datasets were generated with the survival time yi being exponentially
distributed with rate parameter equal to exp[γglog(βgi + 1)] with a censoring probability
of 0.7. The regression coefficient γg was drawn uniformly from the interval [−2, 2], and
βgi ∼ N{βgi>−1}(0, 25.0). The parameters µRg and µGg were simulated as above. We are
primarily interested in the γg parameter, but we also show results of βgi. Figure 5 shows
the γˆg plotted against the true values.
The bars in the plot indicate the 95% HPD intervals. The 95% and 99% HPD intervals
contained the true values of γg 92.0% and 98.5% of the time respectively, which indicates
that the model is estimating γg fairly accurately. Also, the log(βˆgi + 1) were highly
correlated with the true values, see Figure 6. Another test of robustness of the βˆgi as
GEI’s is the correlation that they have with the conventional log-ratio GEI’s. The mean
and median correlation of log(βˆgi + 1) with the log-ratio estimates for each of the 942
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Figure 5: Estimation of Regression Parameter with 95% HPD under misspec-
ified error model.
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Table 5: Operating Characteristics Under True Model
N γg Estimate (SD) γg ∈ 95%HPD γg ∈ 99%HPD 0 6∈ 95%HPD 0 6∈ 99%HPD
950 0 0.0004 (0.18) 0.943 0.99 0.057 0.008
25 1 1.11 (0.24) 0.96 1.0 1.0 1.0
25 -1 -1.01 (0.22) 0.96 1.0 1.0 0.96
genes of interest are 0.90 and 0.97 respectively. These high correlations between the
log-ratio GEI and the latent GEI estimates suggests substantial agreement of the two
estimates of the biological variability present in the data.
An analysis of the operating characteristics of the model demonstrates that the model
has good type I and type II error rate control for inference regarding the γg parameter.
The Ideker et al. (2000) model was used to simulate the datasets, and the same measure-
ment error parameters were used as above with these parameters treated as known. A
total of 1,000 datasets with n = 75 individuals were simulated with 950 genes under the
null (γg = 0) and 50 genes under the alternative (γg = 1 and γg = −1, 25 times each).
The results for the simulation are given in Table 5.
Table 5 shows that the properly specified model has no strong evidence of type I error
rate inflation and has good power for moderate effect size. Also, the HPDs have accurate
coverage probabilities, and the estimated coefficients γg show no indication of bias. For
comparison, we retested the operating characteristics using the log-normal multiplicative
error mentioned above the and using same simulation parameters as well as the same
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Table 6: Operating Characteristics under Misspecified Model
N γg Estimate (SD) γg ∈ 95%HPD γg ∈ 99%HPD 0 6∈ 95%HPD 0 6∈ 99%HPD
950 0 0.004 (0.15) 0.941 0.987 0.059 0.013
25 1 0.989 (0.19) 1.0 1.0 1.0 1.0
25 -1 -0.958 (0.16) 0.92 1.0 1.0 1.0
estimated measurement error parameters. Again, 1,000 datasets were simulated with
n = 75, for fitting the survival model. The results are shown in Table 6.
Table 6 represents the model fit under a grossly misspecified error structure, and
this degree of skewness in the error is greater than that of the observed data. Despite
this large deviation from normality, the model is seen to be quite robust to this kind of
misspecification. One can see a slight inflation of the type I error rate (0.05→0.059 and
0.01→0.013). The power is not seen to decrease, and this may be surprising. However,
one must remember that the measurement error is not the same. The estimates of the
γg coefficients are slightly biased towards the null as would be the case for models that
did not account for measurement error, but this bias does not effect the HPD coverage
probabilities. Overall, the model shows good type I and type II error rate control under
misspecification.
49
2.7 Discussion
This paper presents a model to find associations between a gene’s expression and time-to-
event data for cDNA microarrays that accounts for the substantial measurement error.
The model for the microarray probes is parametric and creates a GEI which is latent
instead using the log-ratio. The model for the time-to-event data is a Bayesian semipara-
metric piecewise constant hazards model. We fit the model using an MCMC algorithm in
a two stage process. The first stage estimates the measurement error parameters, and the
second stage uses these estimates in the survival model on a gene by gene basis. A case
study with a breast cancer dataset is performed with and without adjusting for clinical
covariates. The new model is shown to be generally consistent with a conventional model
that uses the log-ratios in a Cox proportional hazards model, and potentially important
genes selected by the proposed model only are found to have known connections with
breast cancer. That is, conventional models that do not account for measurement error
may fail to detect these genes’ associations between event and gene expression. In addi-
tion to detecting associations, the conventional models may underestimate the strength
of these associations because models not accounting for measurement error are known to
be biased towards the null, and this bias may be avoided in the proposed model. The
model was shown to be robust to some parametric assumptions for inference about the
parameter of interest, and the new GEI’s are found to be highly correlated with the
log-ratios. Further, the model is demonstrated to have good operating characteristics
concerning type I and type II error rates as well as accurate coverage of the parameter
values by the HPDs. However, the issue of False Discovery Rates (FDR) is not addressed
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here. Conceivably, permutation of the survival times could be applied to the data in order
to estimate the false discovery rate. Permutation is regularly applied in the case of the
Cox model and in other frequentist approaches in microarray data Sorlie et al. (2001), yet
such permutations would be not computationally feasible for a Bayesian analysis using
this model, and permutation is only valid under exchangeability which excludes more
complex models with clinical covariates. The problem of estimating FDR for Bayesian
models is one of current research (Efron et al., 2001; Ibrahim et al., 2002; Newton et al.,
2004a; Tadesse et al., 2005), and the estimation of the FDR can be obtained by using
the mean posterior probability. If one is interested in which genes are most likely to be
associated with the time-to-event data, an ordering of the genes in terms of association
is required. In the frequentist setting, the p-values for the test statistics can generate
the ordering. One may easily derive such an ordering from the model presented here by
calculating the posterior probability that γg = 0 as in Tadesse et al. (2005). Overall,
this model has an important advantage over the conventional one in that it accounts for
measurement error which is a significant additional source of variation.
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3 Microarrays and Genetics
The second paper derives an enhanced method for finding associations between genotype
and gene expression. Microarrays represent high-dimension complex traits that can be
influenced by the genotype of the cells. The purpose of genetic analysis of microarray data
is to understand the influence of genotype on gene expression as an intermediary between
genotype and the directly observable complex traits such as blood pressure, cholesterol,
obesity and disease states like diabetes. Linking genotype and expression may help to
elucidate genetic networks as well. Jansen and Nap (2001) asserted that the combined
analysis of gene expression and genetic variation be called “genetical genomics”. Others
have called it eQTL analysis for Expression Trait Loci. eQTL analysis methods are
closely related to Quantitative Trait Loci (QTL) methods that have been developed for
single or a few traits (Lynch and Walsh, 1998). The genetic analysis of quantitative traits
has a very long history dating back to Francis Galton in 1869 (Galton, 1892).
3.1 Fundamentals of Genetics
The basic aim of eQTL and QTL analysis is to find associations between the genotype
which is a set of positively correlated, categorical variables and the phenotype that is a
continuous response. For a review of QTL methods, see Lynch and Walsh (1998).
Experimental or observational design plays a pivotal role in the analysis techniques
used in mapping or detecting eQTL and QTL. The main consideration is whether the
population tested is inbred or outbred. Inbred populations are those whose parents are
closely related. Specifically, recombinant inbred lines (RILs or RI strains) are the results
of multiple generations of brother-sister mating (Lynch and Walsh, 1998). Through
recombination, the offspring will become almost completely homozygous, meaning that
the maternal and paternal chromosomes have the same genotypes. The offspring will
have identical genotypes except for the differences between sexes. Two RILs can be
crossed in different ways depending on the experimental design. For example, F1 designs
compare offspring from the cross of 2 RILs. F2 designs involve the offspring of the F1
generation and so on. The backcross design compares the cross of the F1 line with one
of the parents. The observational designs of outbred populations are very different from
those of inbred populations. Outbred parents and offspring are those whose ancestors
are not closely related. This poses additional analytical challenges compared to inbred
populations, but many important studies of humans involve outbred subjects. Lynch and
Walsh (1998) stress that the outbred designs examine within population trait variability
while the inbred designs examine between population variances, and they give the major
differences between the two. The variability of genetic markers is not well controlled in
outbred populations. For example, markers may not be informative, meaning that the
genotypes are polymorphic (having variation) for the subjects in the study. On the other
hand, outbred parents could have excess variability at a locus. For example, if there are
4 or more genotypes, then the analysis can become less powerful to detect QTLs.
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3.2 Fundamentals of QTL Analysis
The analysis of inbred strains involves the comparisons of means of populations. One
fundamental idea in QTL analysis is that genotype influences the mean value of the trait
y so that
yi = µ+ βxi + i (40)
where β is the QTL effect, and xi is the QTL genotype of the i
th subject, and i is a
random error with variance σ2. The vectors xi and β may be two or three dimensional
depending on the number of different genotypes and whether or not the effect of the
QTL is additive or has a dominance component. If there are three genotypes say QQ,
Qq and qq, then an additive model would have means µQQ + a = µQq = µqq − a for some
a. For dominance models, there is no such a, but there are a and d where µQQ + a =
µQq + d = µqq − a. The location of the QTL or eQTL is generally unknown in advance
so that markers must be used as proxies. One may use the markers themselves, but for
sparse markers, this may have disadvantages such as underestimating the QTL effect and
inaccurate estimation of the QTL location. Interval mapping was developed by Lander
and Botstein (1989) in order to analyze the possible occurrence of a QTL between the
markers. The likelihood for the QTL with additive effect a becomes
L(µ, a, σ2) =
n∏
i=1
[Gi(0)Li(0) +Gi(1)Li(1)] (41)
where Gi(x) is the probability of the genotype x ∈ {0, 1} of the i
th subject. Li(x) is the
likelihood function given genotype x. The probability Gi(x) may be calculated condition-
ally upon the distance from the left and right flanking markers for any position between
them. The above likelihood can be maximized by the Expectation Maximization (EM)
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algorithm for positions uniformly distributed across the genome. This form of interval
mapping is computationally intensive, and eQTL would greatly increase those demands.
The results of interval mapping can be approximated by another more computationally
efficient method of Haley and Knot (1992). They proposed that instead of Equation
(40) one substitutes the expected value of x conditional upon the flanking markers for x.
This allows one to calculate the likelihood for positions between markers like the interval
mapping of Lander and Botstein, but it avoids the burden of the iterative EM algorithm.
Another significant advance in QTL involves correction for multiple QTL affecting a
single trait. If there are many QTL then the model becomes yi = µ +
∑
g βgxgi + i
where the subscript g indexes the different QTL. The existence of multiple, linked QTLs
is known to bias the effect and location of methods that detect the largest single QTL
(Zeng, 1993). Zeng (1993) proposed Composite Interval Mapping (CIM) to overcome
bias due to the composite effects of multiple QTL. CIM models the trait y as a function
of the genotype anywhere in the interval (j, j + 1) between the two flanking markers
j and j + 1 and the genotypes at all other markers. The phenotype model becomes
yi = b0 + b
∗x∗i +
∑
k 6=j,j+1 bkxki + i where k indexes the nonflanking markers. The b
∗
parameter measures the effect of the loci of interest while the bk parameters are the
effects of the background trait variability due to the kth marker. The number of back-
ground markers to adjust for is not given by the model, but the markers j − 1 and j + 2
should always be included because all of the other markers on the same chromosome are
conditionally independent of x∗i .
eQTL detection in human studies must use the analytic methods of outbred analysis.
The underlying model for the means is the same as for inbred populations, but the
55
modeling focuses on the analysis of variance components. In the notation of Almasy and
Blangero (1998), we have y = µ+X ′β+
∑n
i=1 γi+g+i where y is the vector of trait values,
γ is the effect of QTL i, and  is the random error. The term X ′β represents the covariates
(e.g. age, sex) and the corresponding regression coefficients. The g parameter represents
the effects of the polygene which is the composite of many QTLs with small effects.
The variance of y (σ2y) can be written in terms of the independent genetic components∑n
i=1 σ
2
γi
and the random error σ2 so that σ
2
y =
∑n
i=1 σ
2
γi
+σ2g +σ
2
 . The covariance of any
two related individuals is a function of kji which is the probability that the i
th QTL has j
alleles that are Identical by Descent (IBD). Ignoring dominance effects, the covariance of
these two relatives is Cov(y1, y2) =
∑n
i=1(k1i + k2i)σ
2
ai. One may make an approximation
that σ2a =
∑n
i=1 σ
2
ai, and let φ =
1
2
E[(k1i + k2i)] where φ is called the expected kinship
coefficient. This gives Cov(y1, y2) ≈ 2φσ
2
a. If one is interested in QTL i only, we have
Cov(y1, y2) = piiσ
2
ai + 2φσ
2
g where pii = k1i + k2i. The background or polygenic effects are
reflected by σ2g . The term pii is the probability of an allele of the i QTL being IBD and is
called the coefficient of relationship as in Almasy and Blangero (1998). The phenotypic
covariance for a general pedigree may be written as Ω =
∑n
i=1 Πˆiσ
2
ai + 2Φσ
2
g + Iσ
2
e where
the matrix Πˆi has elements (piijl) that indicate the proportion of IBD alleles of QTL i
shared by individuals j and l. Φ is the matrix of kinship coefficients. The estimation
of the Πˆi matrix is not straightforward for general pedigrees, and there are methods
designed for estimating the IBD probability for genetic marker locations (Amos et al.,
1990; Davis et al., 1996) and locations in between markers (Fulker et al., 1995; Almasy
and Blangero, 1998). Almasy and Blangero developed software for general pedigrees that
estimates the Πi matrix for positions between markers with a regression based approach.
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The likelihood for the phenotypes given the form of the covariance matrix is then given
by
log(L(µ, σ2ai, σ
2
g , β|y,X)) = −
t
2
log(2pi)−
1
2
log |Ω| −
1
2
∆′Ω−1∆ (42)
where ∆ = y − µ − X ′β. The hypothesis concerning whether or not QTL i exists is
equivalent to testing σ2ai = 0. Since the test involves the boundary of the parameter
space (σ2ai ≥ 0), the distribution of the likelihood ratio statistic does not have a chi-
square distribution. Self and Liang (1987) showed that the likelihood ratio statistic will
follow a mixture of chi-square distributions, and this null distribution is the basis for
inference.
3.3 eQTL analysis
Most of the existing analyses of and methods for eQTL detection are adaptations of
QTL methods applied to gene expression data. The main difference is that the num-
ber of traits is much increased. Attempts are made to reduce the number of traits or
dimensions that are considered. One motivation is that transcripts with low variation
in expression between genotypes are not likely to be controlled by eQTLs. The removal
of these low variance transcripts is then thought to reduce the number of false positive
eQTL detections as in Schadt et al. (2003). Schadt et al. (2003) excluded transcripts
of low variability, and then used interval mapping with a likelihood ratio threshold to
identify eQTLs for a specific trait. Another motivation for reducing the number of tran-
scripts considered is that some of the expression measurements may not be reproducible
within an genotype. Carlborg et al. (2005) borrowed the concept of repeatability from
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Falconer and Mackay (1996). Repeatability is defined as the ratio of within line variance
to between line variance. Carlborg et al. (2005) showed that when transcripts with low
repeatability are excluded, the power for detection of eQTLs is increased. However, as
Schadt et al. (2003) and Chesler et al. (2005) point out, excluding subsets of transcripts
may increase the number of false negatives or non-discoveries. Instead of excluding sets
of transcripts, the dimension of the phenotype may be reduced by combining transcripts
to form a smaller number of “supertraits.” Yvert et al. (2003) reduced the number of
individual traits by clustering groups of genes that were significantly correlated, and the
mean expression level of transcripts in the cluster was the quantitative trait considered.
Lan et al. (2003) proposed that the principle components of the gene expression data
and clusters based on transcripts of interest could be used as supertraits to improve the
power of eQTL detection.
The attempts to control false discovery or Type I error rates in eQTL analyses have
mostly been derivative of the methods applied to QTL framework. Schadt et al. (2003),
Morley et al. (2004), and Monks et al. (2004) used a genome-wide p-value cutoff based on
a Bonferroni correction to all possible eQTL associations. Chesler et al. (2005), Hubner
et al. (2005), and Carlborg et al. (2005) used a combination of a genome-wide permutation
p-value and the FDR estimation method of Storey (2002). The permutation procedure
of Churchill and Doerge (1994) was applied to each transcript. This procedure simply
permutes the trait (transcript) values, and calculates the test statistic for each loci on the
genome. The maximum test statistic across the genome for each permutation gives an
empirical null distribution. The observed test statistic is then given a p-value according
to this null distribution. In these eQTL experiments, this p-value is then entered into
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Storey’s q-value procedure so that the FDR can be computed.
Very recently, Storey et al. (2005) have developed a method that uses a forward
selection process to create a multiple eQTL model, meaning that many loci affect the
mean expression level of a transcript. The method proceeds as follows. First, for each
transcript, the loci on the genome with the highest likelihood of association is chosen
using a method related to Efron (2004) that calculates an empirical Bayes estimate of
posterior probability for association. Next, the effect of the chosen loci is included in
the model for each corresponding transcript, and the procedure selects the loci with
the highest probability of association with the transcript given the loci selected in the
previous stage. The posterior probability that both loci selected in the two rounds of the
procedure are associated with the transcript is given by
P{loci 1 and 2 are associated|Data} = P{locus 2 associated|Data, locus 1 associated}
×P{locus 1 associated|Data}. (43)
This methods allows for the FDR to be calculated as the average posterior probability of
no association (1− P{loci 1 and 2 are associated|Data}) for the selected subset of traits
with two loci models. The forward selection can be applied for more than two levels, but
forward selection procedures are generally known to be biased. Whether or not this bias
affects the biological inferences is not known at this point.
3.4 Data Structure
The motivating dataset that we consider is from an experiment on brain tissue from
mouse recombinant inbred (RI) strains with Affymetrix microarray measurements. The
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microarray dataset is available from www.genenetwork.org by searching for mouse data,
BXD group, and whole brain tissue. RI strains are the product of multiple generations
of inbreeding that result in offspring that are homozygous for either of the two founding
parents. BXD (B strain crossed with D strain) strains have homozygous alleles of either
one of two parents B (C57BL/6J) and D (DBA/2J). The BXD panel and RI panels in
general have several advantages for eQTL mapping experiments (Chesler et al., 2004).
The RI mouse model has been broadly used for the genetic exploration of complex dis-
eases and as a model of human disease (Chesler et al., 2004). The RI strains are a
renewable source of genetically identical animals that can be used in experiments that
are reproducible from laboratory to laboratory. The genetic identity reduces the need
for genotyping and facilitates exploring gene by environment interactions. Also, there
are continuously evolving databases for comparison and integration of results. In this
paper, the model is applied to RI designs, but it can be applied to many breeding designs
such as backcross or F2. The basic goal of eQTL detection is to find associations between
the categorical predictors (genotypes) and the continuous response (transcript expression
level). (For a general reference on QTL analysis, see Lynch and Walsh (1998)). In the
most simple circumstance and in the case of RI strains, the genotypes are of two varieties
denoted as 0 or 1. The genotype of any individual k out of n is then a vector of length
M of 0’s and 1’s where M is the number of genetic markers. The index for the transcript
will be t out of T . The microarray measurement for a transcript t is given by yt so that
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we have
yt ≡ Vector of gene expression measurements for transcript t.
yt,m,g ≡ Subvector of yt for individuals having genotype g at marker m.
The transcripts can be either equivalently expressed (EE) meaning that genotypes
are not associated with expression level or differentially expressed (DE) meaning that
one or more marker loci are associated with the transcript’s expression.
3.5 The Mixture Over Markers Model
The False Discovery Rate (FDR) is often used to account for the multiple testing problem
in microarray analyses, but the multiple testing methods typically applied to microarray
data like the q-value method can be anticonservative in the eQTL setting as Kendziorski
et al. (2005) point out. The reasons for the shortcoming of these methods are manifold,
but the main reason is that FDR methods developed for microarrays typically consider
only one alternative hypothesis. That is, the alternative hypothesis is that the transcript
is differentially expressed with respect to or correlated with a single biological state. In
eQTL analyses, any given transcript has alternative hypotheses for each marker. That
is, a transcript could be associated with marker 1, 2, 3, etc. This adds another dimension
to the multiple testing problem. In QTL analyses, the existence of merely an association
between a marker and a trait is not a sufficient discovery because the QTL discoveries
are optimally localized to minimal regions of highest association, not merely some asso-
ciation. Kendziorski’s MOM method (Kendziorski et al., 2005) has the advantage that it
simultaneously estimates posterior probabilities of all of the MT possible associations be-
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tween transcripts and markers. The result of fitting the MOM model gives the posterior
probability of a transcript being associated with a certain marker based on the observed
data. This has at least three advantages. First, by averaging the posterior probabilities,
one can estimate the FDR. Second, for every transcript, one has the conditional proba-
bilities for an eQTL across all of the markers. Returning to the previous example, the
MOM model gives the posterior probabilities that transcript t is associated with markers
1, 2, or 3, simultaneously. Third, the model pools information to estimate parameters
common to all transcripts.
The MOM model does have some disadvantages. First, the MOM model assumes at
most one locus explicitly controls the expression of a given transcript which may not hold
for some transcripts. In the QTL literature, there are some methods that are developed
which can estimate the number as well as the location of QTLs, but these methods may
not be readily applied in the eQTL setting because of the sheer computational burden
(Storey et al., 2005). We propose an extension of the MOM method to model two eQTLs
conditionally upon finding the first major eQTL. Second, the MOM method assumes
that the error variances are equal within predetermined transcript clusters. We relaxed
this assumption and suggest a discrete uniform prior for the standard deviations of the
errors.
When considering all possible MT associations between transcripts and markers it
could be advantageous to utilize the patterns of these associations. Chesler et al. (2004)
and Carlborg et al. (2005) noted that transcripts are more likely to be associated with
markers that correspond to the genomic location of the transcript. eQTLs that are as-
sociated with the transcripts of nearby genes are called cis acting eQTLs while eQTLs
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that are associated with transcripts that are some distance away are called trans acting
eQTLs. There are biological reasons for the prevalence of cis eQTLs. Namely, the lo-
cal DNA sequence may contain elements that affect the transcript’s regulation or subtly
affect the transcript’s function (Doss et al., 2005). This biology is one of the major mo-
tivations for developing the proposed extension of the MOM method to include genomic
locations of the transcripts and markers. There is a possibility that a putative cis eQTL
is an artifact of sequence variation in the transcript affecting the expression measure-
ment process. However, Doss et al. (2005) examined putative cis acting eQTLs in mice
and experimentally confirmed that a majority of these associations corresponded to true
eQTLs.
First, we describe the MOM model. The marginal likelihood for EE transcripts is
f0(yt) =
∫
f∗(yt|σ
2)piσ2(σ
2)dσ2, (44)
where
f∗(yt|σ
2) =
∫ ∏
k
fobs(yt,k|µt, σ
2)piµ(µt)dµt, (45)
and
fobs(yt,k|µt, σ
2) = φ(yt,k;µt, σ
2) and piµ(µt) = φ(µt;µ0, τ
2
0 ). (46)
The transcription measurements are considered independent sampling units. The term
fobs(yt,k|µt, σ
2) is the distribution of yt,k (the k
th element of yt) conditional on σ
2 and the
mean µt, which for EE transcripts, is the same for all subjects. fobs represents residual,
non-genetic variation and genetic variation not explained by the model. The parametric
form of fobs is φ(yt,k;µt, σ
2) where φ(x;µ, σ2) is the normal density with mean µ and
variance σ2. One may integrate out the µt parameter and find that f∗ is a multivariate
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normal density with mean µ0 and a compound symmetric variance Iσ
2 + 11′τ 20 where 1
and I are the vector of ones and the identity matrix respectively.
In Equation (44), the prior for σ2 is denoted as piσ2 . In Kendziorski et al. (2005),
there is no prior on σ2, but the error variance is chosen to be equal within clusters.
These clusters are chosen using the k-means algorithm before MOM is applied. We
argue that there is no a priori reason to assume that genes have equal variances because
they are correlated. Further, the uncertainty in the clustering of genes is not accounted
for when the variance categories are fixed before the model fit. We choose a discrete prior
for σ2 so that σ is uniformly distributed over the interval [0, σ∗] to cover the range of
probable variances where σ∗ is determined by estimating the variances of a subset of genes
thought to be EE. Equation (44) implies that f0 is a scale mixture of compound symmetric
densities. Differentially expressed (DE) transcripts associated with marker m would have
density fm(yt) =
∫
f∗(yt,m,0|σ
2)f∗(yt,m,1|σ
2)piσ2(σ
2)dσ2 where the corresponding fobs are
centered around a different mean (µt,m,0 or µt,m,1) according to the genotype of marker m.
This implies that fm is a scale mixture of block diagonal compound symmetric normal
densities.
The status of whether or not the transcript is differentially expressed and if so, which
marker(s) is it associated with is not known a priori, and this is treated as missing data.
In a fully Bayesian context, one would estimate the joint posterior distribution for both
the parameters and the missing data. Although such joint estimation would be ideal,
the number of missing data points is MT which makes such fully Bayesian estimation
computationally infeasible using MCMC methods. As a computationally feasible alter-
native, we consider an Empirical Bayes procedure in which the parameters are estimated
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by maximizing the marginal likelihood. If we consider only marker m and let pm be the
probability of a transcript t being associated with marker m, then the marginal distri-
bution of the data is given by Lt,m = pmfm(yt) + (1 − pm)f0(yt). This model may be
extended over many markers. We let p0 be the prior probability of the transcript mapping
nowhere (i.e., the null hypothesis that the transcript is not associated with any marker)
and equate the mixing proportions pm with prior probabilities for the marker being an
eQTL for a transcript. One may notice that the prior probabilities pm for a transcript
mapping to a particular marker are not dependent on the particular transcript. The
likelihood now becomes Lt = p0f0(yt) +
∑M
m=1 pmfm(yt) where M is the total number of
markers considered. So the likelihood for all transcripts and markers is L =
∏T
t=1 Lt. The
model is fitted with the expectation maximization (EM) algorithm. EM is used because
the binary (0 or 1) (M+1)×T dimension matrix Z of random variables (zm,t) that deter-
mine which marker, if any, is associated with the transcript t are not observed. The case
z0,t = 1 implies that transcript t is not controlled by any marker, and the case zm,t = 1
implies that transcript t is controlled by marker m. Thus, if the zm,t were observed, we
would have the complete data. The columns zt of the matrix of zm,t are multinomial
random variables which contain exactly one 1 when observed and have elements whose
expectation sum to unity. This model considers the existence of only one major eQTL.
The complete data log-likelihood for a given transcript can be rewritten in terms of these
zm,t as
lt =
M∑
m=0
zm,t log(pm) +
M∑
m=0
zm,t log(fm(yt)). (47)
The above equation illustrates that the mixture probabilities pm can be thought of as
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the prior component with the fm(yt) being the likelihood component. This equation also
indicates that zt has multinomial probabilities p0 . . . pM that can be estimated directly
with the EM algorithm by substituting the expectation of zm,t. The expectation of zm,t is
an important quantity that is equal to the posterior probability of a transcript mapping
to the marker m and is given by
E[zm,t] =
pmfm(yt)∑M
m=0 pmfm(yt)
. (48)
3.6 Extensions of the MOM model
We describe the proposed extensions of the Mixture Over Marker model, the model fitting
procedure, and the calculations of the FDR.
3.6.1 Proximity Model
We extend the MOM model to allow the prior probabilities of a transcript mapping to
a marker to depend on the transcript’s genomic proximity to the marker. We choose a
simple and reasonable relationship to model these prior probabilities. We use a log-linear
model for the mixture probabilities pm,t that contains the Kendziorski model as a special
case. The responses in the model are the multinomial columns zt of the Z matrix that can
be converted into a (M + 1)× (M + 1) contingency table ζ with elements ζij =
∑
t∈Ci
zj,t
where Ci ≡ {t | t closest to marker i}. The element ζij is the number of transcripts
closest to marker i that map to marker j where i, j ∈ {0, 1, . . . ,M}. The 1st row of ζ (ζ0j)
represents transcripts that were not sufficiently close to any marker. The 1st column of
the ζ (ζi0) represents the transcripts mapping to no marker. Converting Z into ζ allows
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the reduction of the data from (M + 1) × T elements of Z to the (M + 1) × (M + 1)
elements of ζ because T is often several times larger than M . A log-likelihood is derived
under the assumption that the ζij’s are a vector of random variables that have a Poisson
distribution. This generalized linear model with the canonical link is proportional and
equivalent to a multinomial likelihood for the zt’s. The linear, systematic component of
the model for the elements of the table is
log(E[ζij]) = νij = αi + βj + γI[i = j]I[i > 0] (49)
where I[ ] is the indicator function. The I[i > 0] term exists because the first row of
the table corresponds to transcripts that are not close to any marker. The parameters
α0 . . . αM are nuisance parameters that model the row totals so that the log-linear model
and the multinomial models are equivalent. The parameters β0 . . . βM correspond to the
marker specific effects. The β0 parameter is related to the log prior probability that
a transcript is not associated with any marker. Because the multinomial probabilities
must sum to 1, one of the βm parameters is determined by the others, and without loss
of generality, we set β0 to 0. The size of βm varies greatly. Some markers do not appear
to regulate any transcripts while other markers might modulate hundreds of transcripts.
The γ parameter represents the effects of proximity and is the increase (if γ > 0) in prior
probability of a transcript being associated with the closest locus. Explicitly, the prior
probability for zm,t is
pm,t(β, γ) =
exp(βm + γI[m is closest marker to t])∑M
m′=0 exp(βm′ + γI[m
′ is closest marker to t])
. (50)
It is clear that if we fix t then
∑M
m=0 pm,t = 1. If γ = 0, then the log-linear model
becomes equivalent to the Kendziorski’s multinomial model for the mixture proportions
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zm,t. The modeling of the mixture proportions adds some numerical difficulties because
some markers (say marker m) may not be associated with any transcripts which precip-
itates convergence problems because this implies βm → −∞. This may be alleviated by
using a normal prior on the β parameters. These priors may be easily implemented by
the method of Knuiman and Speed (1988) who developed these models to utilize prior
information for contingency tables, but they noted that these priors also accommodate
fitting with low frequency cells in tables. We chose a diffuse prior such that β ∼ N(0, σ2β)
which is both a sensible prior and is equivalent to using a small ridge parameter that
we denote as λ = 1
2σ2
β
. These normal priors can be fit by adding a penalty parameter
to the iterative weighted least squares algorithm. We observed that the inferences were
insensitive to the prior choice of λ. The model performed well for values of λ between
10−2 and 10−4 which imply a large prior variance for βm.
It is worth mentioning that the proximity model is identifiable when the MOM model
is not. For example, if there are two or more flanking markers with identical geno-
types, then the MOM model is incapable of distinguishing between them so that the
prior probabilities of these markers would be nonidentifiable. In the proximity model,
the markers would be differentiated by their proximity to different transcripts, and the
posterior probability for being an eQTL would be highest for the closest markers.
3.6.2 Model Fitting
We use a variant of the EM algorithm (Dempster et al., 1977) known as the Expecta-
tion Conditional Maximization (ECM) algorithm (Meng and Rubin, 1993). The full log
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likelihood conditional on zm,t is
l =
T∑
t=1
M∑
m=0
zm,t log(pm,t(β, γ)) +
T∑
t=1
M∑
m=0
zm,t log(fm(yt|Ω)). (51)
A convenient aspect of this model is that the β and γ parameters can be estimated
independently of Ω = (µ0, τ
2
0 ) conditionally on the expectation of zm,t. The expectation
of zm,t is
E[zm,t] =
pm,t(β, γ)fm(yt)∑M
m=0 pm,t(β, γ)fm(yt)
. (52)
The ECM algorithm begins by choosing initial values for all of the parameters. The
expectation of zm,t is then calculated. Next, we maximize the expected log-likelihood
over the β and γ parameters. There are a few considerations when fitting this model that
were not previously mentioned. First, the transcripts should be ordered by their genomic
locations to facilitate the collapsing of Z into the table of ζij. Second, sparse matrix
operations effectively reduce the computation time. The dimension of the design matrix
is ∼ M2 × 2M which might cause the usual generalized linear model fitting procedures
to fail because of computer memory and time limitations. We used the sparse matrix
operations package developed by Koenker and Ng (2003) to implement the iteratively
weighted least squares algorithm with the λ ridge parameter to fit the generalized linear
model. The next step of the algorithm is recomputation of the expected value of zm,t.
Then, the Ω parameters are maximized. We maximize these parameters with a generic
optimization algorithm provided by the R nlm function (R Development Core Team,
2004b). The ECM algorithm continues alternately conditioning on Ω and the β and γ
parameters until convergence.
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3.6.3 Calculation of the False Discovery Rate
We estimate the FDR in a similar manner as Kendziorski et al. (2005) and Newton et al.
(2004b). The determination of the FDR depends on the calculation of the posterior
probabilities of EE (pEE,t) and DE (pDE,t = 1− pEE,t) for each transcript. This is given
by
pEE,t = E[z0,t] =
p0,tf0(yt)∑M
m=0 pm,t(β, γ)fm(yt)
. (53)
To control the FDR to be less than α, we choose a threshold κ(α) for the pEE,t so that
if pEE,t < κ(α) then the transcript is identified as DE or mapping to some marker. For
any given κ(α), the FDR is
FDR =
∑T
t=1 pEE,tI[pEE,t < κ(α)]∑T
t=1 I[pEE,t < κ(α)]
≤ α. (54)
The FDR is the average posterior probability of being EE of those transcripts that are
selected as DE. In most nontrivial cases, some of the pEE,t that are averaged will exceed
the FDR. We have seen in real data analyses that controlling FDR alone could lead to a
poor decision rule which results in a κ > 1
2
. This implies that some transcripts declared
to be DE may have pEE,t >
1
2
. Thus, we advocate controlling κ, but the FDR remains a
useful summary measure of the overall reliability of a set of inferences. Particularly, the
FDR is useful for comparing the average reliability of lists generated by different methods
as is done with the simulations of Section 3.7.
3.6.4 Multiple eQTL extension of the MOM model.
Multiple eQTL may be discovered using the following extension based on a forward model
selection process. We consider the 2 eQTL case. In the first stage, one applies the MOM
70
or the Proximity Model to select the most likely associated marker for each transcript
identified as DE. Call these markers m∗t . In the second stage, one fits a variant of the
MOM model for the case of 2 eQTLs which we describe below. We condition on the
event that the transcript t has at least two means based upon the genotypes of marker
m∗t . Let yt,mi,gi,mj ,gj be the subvector of yt that contains observations from individuals
having the genotypes gi and gj for markers mi and mj respectively. The density for a
transcript mapping to 2 markers (m∗t and another marker m) is given by
fm∗t ,m(yt) =
∫
f∗(yt,m∗t ,0,m,0|σ
2)f∗(yt,m∗t ,0,m,1|σ
2)f∗(yt,m∗t ,1,m,0|σ
2)f∗(yt,m∗t ,1,m,1|σ
2)piσ2(σ
2)dσ2.
(55)
This is a natural extension of the definition of fm(yt) in Section 3.5 and represents a
2 eQTL model with 4 different means corresponding to the 4 different genotype com-
binations. The marginal likelihood of the transcript data becomes Lt = p1fm∗t (yt) +∑
m6=m∗t
p2fm∗t ,m(yt) where p1 is the prior probability of being associated with one marker
only, and p2 = (1 − p1)/(M − 1) is the prior probability of mapping to any one of the
additional M − 1 markers. One may fit this model using the EM algorithm as described.
The posterior probability of a transcript being only associated with marker m∗t is denoted
as pEE2,t ≡ E2[zm∗t ,t], and can be estimated by
E2[zm∗t ,t] =
p1fm∗t ,m∗t (yt)
p1fm∗t ,m∗t (yt) +
∑
m6=m∗t
p2fm∗t ,m(yt)
. (56)
Controlling the FDR in the setting of forward model selection is possible by calculating
the conditional probabilities using the method of Storey et al. (2005). The FDR of the
second stage is calculated based upon the posterior probabilities of the second stage
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conditionally upon the posterior probabilities in the first stage. That is,
P{m∗t and additional marker are associated with t|Data}
= P{Additional marker associated|Data, marker m∗t associated}
×P{marker m∗t associated|Data}
= (1− pEE2,t)× E[zm∗t ,t]. (57)
where E[zm∗t ,t] is calculated as in Equation (48). The FDR of the second stage is the
average of 1− P{m∗t and additional marker are associated|Data} for the selected subset
of transcripts with two loci models. Fitting more than 2 eQTLs proceeds with similar
arguments.
3.7 Simulated Data Analysis
We performed analyses under the controlled setting of simulated data in order to ex-
plore the operating characteristics of the proposed proximity model in comparison to
the previous MOM model. The comparison is between the realized performance of both
methods in terms of power and FDR control. The definition of power and false discovery
rate for eQTL analyses is not trivial and should be defined. We define power to be the
probability of identifying a transcript as DE with the posterior distribution of an eQTL
having a maximum at the true location of an eQTL. That is, power is the probability of
detecting the true eQTL and localizing it to the correct position. We define the realized
FDR to be the probability of the union of two mutually exclusive events. First, the model
declares a transcript is associated with any marker when the transcript is independent of
all markers. Second, for those transcripts associated with a marker, the model declares
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the transcript to be associated with some marker, but neither the true eQTL nor the
flanking markers are in the 90% Highest Posterior Density (HPD) region. We defined this
HPD region as the minimal set of markers whose combined posterior probabilities of as-
sociation with the transcript is greater than or equal to 90%. The formula for calculating
the realized FDR is given by
# of Transcripts Falsely Identified as DE + # of Transcripts Incorrectly Localized
# of Transcripts Identified as DE
.
The simulation experiment details follow. A total of 500 datasets were simulated with
100 datasets for each value of γ = [0.0, 2.0, 4.0, 6.0, 8.0]. These values of γ correspond to
increases in prior probability of a transcript being controlled by the closest marker. The
corresponding proportions of DE transcripts that were controlled by the closest marker
were [3%, 17%, 59%, 91%, 98%]. Each dataset had 500 transcripts and 30 markers equally
distributed amongst 3 chromosomes evenly spaced with a 10 cM distance between. The
transcripts had a 0.6 probability of being EE, and the eQTL were uniformly distributed
across markers. The genotypes of n = 60 individuals were simulated once and held fixed
for all datasets. Realistic distributions were chosen for piµ, piσ2 , and fobs. To generate
these distributions, the MOM model was applied to the BXD dataset described in the
next section. We used this model to find a subset of about 5, 000 transcripts that were
EE. For piµ, we resampled the distributions of the sample means of these transcripts. For
piσ2 , we independently resampled the distribution of the corresponding sample variances,
and the non-genetic error distribution fobs was simulated by independently resampling the
empirical deviations of the EE transcripts about their sample means. To fit our model,
we chose σ∗ to correspond to the 99% quantile of piσ2 and chose 10 points uniformly within
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this range for the discrete prior. We fixed our false discovery rate at 0.05 as calculated
by Equation (54). The ridge parameter was selected to be λ = 0.05 which implies that
β ∼ N(0, 10) and gave stable results which converged quickly. For comparisons against
a naive method, we used a t-test comparing the means of the genotypes at each marker.
We then calculated the q-values of all MT tests. We declared a relationship between
marker and transcript if the q-value was < 0.05. The power of the t-test approach is
defined to be the probability of finding the true eQTL at the marker having the minimal
q-value. The realized FDR is similarly defined as the probability of the union of two
events for a transcript. The first event is declaring a transcript to be associated with
some marker when it is independent of all markers. Second, for transcripts that have an
eQTL, the transcript is declared to be DE, but the true eQTL and flanking markers all
have q-values that are > 0.05.
The results are shown in Figure 6 and Figure 7. In Figure 6, there are three power
plots representing the overall power to detect eQTLs, the power to detect the cis subset
of eQTLs, and the power to detect the trans subset of eQTLs.
The similarities in power occur because the models are closely related, however, one
may see that the overall power of the proximity model is higher than the power of the
MOM model as γ becomes large. It may be surprising to see that the power of the
proximity model is maintained even if the γ parameter is 0. This is because the γ
parameter is estimated to be close to zero when γ = 0 in the proximity model. As one
might expect, the power advantage of the proximity model is increasing for increasing
values of γ, and the differences in posterior inferences are substantial for a subset of
transcripts as will be seen in the next section. The power advantage appears to be due to
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Figure 6: Simulated Data: Power Comparisons with 95% confidence intervals
as a function of the proximity effect γ. The overall power is shown on the left.
The power plots by cis transcripts and trans transcripts are middle and right.
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the prevalence of cis transcripts, but the MOM model has a more variable corresponding
power advantage for detecting trans eQTLs. The FDR comparison is shown in Figure 7.
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Figure 7: Simulated Data: FDR Comparisons with 95% confidence intervals
as a function of the proximity effect γ.
The naive method called “T q-value” has similar power to the MOM method, but it
controls the FDR very poorly with a mean FDR of 0.155 and 95% CI (0.114, 0.197)
which is much higher than the target FDR of 0.05. This result is consistent with
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Table 7: Simulated Data Parameter Estimates
Parameter Sample γ = 0 γ = 2 γ = 4 γ = 6
MOM µ 5.848 5.85 (0.06) 5.85 (0.06) 5.85 (0.06) 5.85 (0.06)
Model τ0 1.615 1.61 (0.04) 1.61 (0.04) 1.62 (0.05) 1.62 (0.04)
Proximity µ 5.848 5.85 (0.07) 5.85 (0.06) 5.85 (0.06) 5.85 (0.06)
Model τ0 1.615 1.61 (0.04) 1.61 (0.04) 1.62 (0.05) 1.62 (0.04)
γ - -0.14 (0.60) 1.99 (0.21) 4.05 (0.16) 5.99 (0.30)
Table 8: Simulated Data Parameter Estimates Continued
Parameter Sample γ = 8
MOM µ 5.848 5.86 (0.06)
Model τ0 1.615 1.62 (0.05)
Proximity µ 5.848 5.86 (0.06)
Model τ0 1.615 1.62 (0.05)
γ - 7.42 (0.33)
Kendziorski’s observations. The average realized FDR of the proximity model is 0.0434
with 95% CI (0.0303, 0.0623) compared to the MOM average FDR of 0.0419 with 95%
CI (0.0235, 0.0587). Tables 7 and 8 show the estimates of the remaining parameters with
their standard deviation over the simulated datasets.
The µ0 and τ0 parameters were estimated accurately by both models. The γ parameter
was only estimated by the proximity model, and one may notice accurate estimation.
The 2 eQTL model was fit to 100 datasets simulated with the same distributional
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assumptions and genotypes as above. There was no effect of proximity (γ = 0), and
n = 60. The probability of EE was 0.6, and the probabilities of a transcripts being
associated with one or two eQTLs were 0.2 and 0.2, respectively. The positions of the
eQTLs were chosen independently of one another with uniform probability throughout
the genome. The two stage fitting procedure was applied, and the threshold κ for pEE,2
and pEE was set to 0.05. This method identified both eQTLs at the modes of the posterior
distributions 72% of the time. The FDR for declaring associations with these 2 eQTLs
was defined as having the posterior mode of the 2 eQTLs outside of the flanking markers
for both eQTLs or declaring associations when there are none. The average FDR was
0.016 with a 95% CI of [0.0,0.046], and the average nominal FDR was estimated to be
0.049 so that the realized FDR is conservatively controlled.
3.8 Case Study: BXD Dataset
There were 32 BXD strains considered and each of the strains included were sampled
from 1 to 4 times for a total of n = 88 mice. The Affymetrix U74Av2 chip was used
which contained a total of T = 11, 935 transcripts with known percent identity to genome
locations that are available from Affymetrix (www.affymetrix.com). We chose the tran-
script to be located at the sequence with highest identity. The 277 markers were used
with a median spacing of 4 cM. The markers were located on chromosomes 1 to 19 and
on the X chromosome. The determination of which marker was closest was made using
the Build 33 distances between the transcripts and the markers. Build 33 refers to the
version of the mouse genome map used to locate the transcripts and markers. If the tran-
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Table 9: BXD Analysis: Comparison of Parameter Estimates from Mouse
Experiment Data with the Standard Deviations in ().
Parameter MOM Model Proximity Model
µ̂0 6.1439 (0.00003) 6.1443 (0.00006)
τ̂0 1.5372 (0.00002) 1.5371 (0.00006)
γ̂ - 3.6070 (0.008)
script was further than 5× 106 base pairs away from any marker then it was considered
to be not close to any marker. Only 12% of transcripts were not close to any marker
by this standard. Some of the markers had missing data which accounted for 1% of all
genotypes. We imputed this missing data by sampling genotypes conditionally upon the
flanking markers as in Lynch and Walsh (1998). The variability between imputations of
the final results was very small and affected < 0.1% of transcript inferences because of
the high density of the markers leading to 99.7% agreement between the imputations of
the genotypes. Because of this small variability and computational time constraints, we
performed 5 imputations and report the average result.
The raw microarray data was preprocessed with the Robust Multichip Average (RMA)
(Irizarry et al., 2003) software to summarize the probe level data and normalize the
microarrays, and this output was used as the expression level for each transcript. The
MOM method was applied using our implementation. We chose σ∗ as discussed in the
simulation section and chose 30 points uniformly within this range for the discrete prior.
Next, we applied our extension of the MOM method to the data, and we compared
our results. Table 9 shows the estimates for the Ω and γ parameters.
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Table 10: BXD Analysis: Comparison of Differentially Expressed Genes
Parameter Estimates from Mouse Experiment Data
Posterior Probability Threshold κ = 0.05
Proximity Model
DE EE Total
MOM DE 370 11 381
Model EE 30 11524 11554
Total 400 11535 11935
Estimates of µ0 and τ are identical to three digits. The γ parameter is equal to 3.61
which indicates that the proximity model increases the prior probability of a marker being
associated with a nearby transcript by a factor of about exp(3.61) ∼ 40. We now compare
the conclusions regarding which transcripts are differentially expressed. One might select
the false discovery rate which implies a threshold for the posterior probability. An FDR
cutoff of 0.05 is often used, but this can lead to false discoveries that can be easily avoided.
The rule that we adopted is that the posterior probability of DE is > 0.95 which implies
a FDR of 0.011. The genes selected by this criterion for the posterior probability of DE
are very similar in both models as shown in Table 10.
The proximity model selects most of the genes selected by the MOM model as well
as 30 other genes which is consistent with higher sensitivity of the proximity model in
finding associations between genotypes and gene expression when γ > 0. It is important
to point out that the structure of the proximity model will map more transcripts to
the closest marker on the genome. All 30 of the transcripts selected as DE only by the
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proximity model were cis, and all 11 of the transcripts selected as DE only by the MOM
model were trans. Some of these transcripts with the largest differences between the two
methods are shown in Figure 8.
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Figure 8: BXD Analysis: Posterior distribution of eQTL for selected tran-
scripts. Transcript 96629 at shows differing posterior distributions between
the models. Transcript 102287 at demonstrates the proximity model gives
a highly localized eQTL HPD compared to a weaker, more diffuse posterior
distribution of the MOM model.
In Figure 8, the posterior modes are mapped more closely to their genomic location
by the proximity model while the MOM model may map the transcripts to different
81
chromosomes resulting in quite different posterior inference. These models were used to
select the most likely marker to be associated with the differentially expressed transcripts
(m∗t ). Of the 370 transcripts selected by both models, 15 had different values for m
∗
t . This
would likely affect the results of any forward building model selection process based upon
m∗t . We performed the two eQTL analysis on this dataset, and we found that among
the 400 transcripts selected to be associated with one eQTL, there were 185 transcripts
declared to be associated with 2 eQTLs with posterior probability greater than 95% given
the first eQTL.
We considered the robustness of inference to the selection of the ridge parameter, and
values of λ = 1
2σ2
β
ranging from 10−2 to 10−4 did not greatly effect inferences regarding
transcripts. Further, the selection of the number of discrete variance points from 10 to
30 did not greatly affect inferences.
3.9 Discussion
We have developed a proximity model for finding eQTL which includes explicitly mod-
eling the effect of genome location by extending the MOM model of Kendziorski et al.
(2005). The model adds a data-driven increase in the prior probability of a transcript
mapping to the marker that is closest on the genome. We have also extended the MOM
model to include more than one eQTL and have allowed for transcript specific variances.
We have shown that this proximity model can be implemented in an efficient manner, and
that it has favorable performance in terms of power while controlling the false discovery
rate. The proximity model performs well compared to the MOM model in simulated
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datasets with moderate to large proximity effects, but the MOM model may have more
power to detect trans associations even when the proximity effect is large. The model
was applied to an experimental dataset, and the MOM and the proposed model gave
similar overall results regarding the genetic control of transcripts. However, the proxim-
ity model suggests that a greater number of transcripts are associated with eQTLs than
the MOM model, and it was shown that the MOM model gave different localizations
of eQTLs regarding some transcripts. Furthermore, we showed that roughly half of the
transcripts are likely to be associated with a second eQTL. We chose a simple model for
the increase in prior probability of a transcript mapping to the closest marker. However,
we considered more complex models such as ones that would make the prior probability
a decreasing function of the distance of a marker and the transcript. These other models
add interpretational and computational difficulties, and they do not reflect any widely
accepted biological understanding not captured by the model we used. Lastly, we note
that controlling the FDR alone could result in poor decision rules for certain cases as the
FDR is a summary statistic for a set of hypotheses, but does not strictly control the pos-
terior probability of the individual alternative hypotheses. Thus, we suggest controlling
the posterior probability of individual hypotheses instead.
In future research, we will explore how the ridge parameter may be estimated from the
data through a mixed model or empirical Bayes methods which would use the information
across markers to regularize the parameter estimation. We also note that this framework
of modeling the prior probability of differential expression across transcripts and markers
can be readily extended to include other parameters for sequence characteristics like the
presence of features in the sequences known to involve transcription regulation. We chose
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the prior for the error variance piσ2 to be discrete and noninformative, but future methods
could model this density semiparametrically so that the prior becomes more informative
resulting in higher power. Also, we used a limited number of imputations of missing
genotypes, but in applications involving less dense maps, more imputations should be
performed which might require more efficient computational implementations.
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4 Microarrays for Binding Site Discovery
The third paper advances an analytic method that integrates microarray data and the
sequence analyses of the probes to discover transcription factor binding sites. The spe-
cific hybridization of DNA microarrays can be used in ways other than the measurement
of expression. The method of Chromatin (Ch) Immunoprecipitation (IP) microarrays
(ChIP-Chips) use microarrays of DNA sequences to measure specific DNA-protein inter-
actions. The ChIP-chip technique is reviewed by Buck and Lieb (2004). The goal is to
discover the genomic locations of transcription factor binding sites (TFBSs). Transcrip-
tion factors are proteins that regulate the expression of nearby genes by binding to DNA
and interacting with RNA polymerase (Stryer, 1995) which is the enzyme responsible
for transcription. Gene transcription is often locally regulated so that knowing the lo-
cation of the TFBS can give insight into which genes are regulated by the transcription
factor. Identifying the conditions that transcription factors are active in is important to
understanding the role a transcription factor has in certain biological processes and de-
velopmental stages. Transcription factors bind to TFBSs with specific sequence patterns
that are usually on the order of 10 nucleotides in length, and even in relatively small
genomes, the binding sites occur in thousands of locations (Buck and Lieb, 2004). The
chromatin immunoprecipitation procedure concentrates specific DNA-Transcription Fac-
tor complexes in the following manner. First, the transcription factor of interest binds to
the DNA in vivo under controlled conditions, and the extracted protein-DNA complexes
are fixed or crosslinked. The DNA is broken into 1kb fragments by sonication. Next, an
antibody specific to the transcription factor of interest binds to the protein-DNA com-
plex, and this entire complex precipitates out of solution. The DNA is then extracted,
and the DNA is amplified and labeled. We call this the IP sample. Control samples
of DNA that do not go through the IP process are used as a reference, and either two
color microarrays (Buck and Lieb, 2004) or high density oligonucleotide arrays (Kapra-
nov et al., 2002; Cawley et al., 2004) compare the DNA present in the IP sample and the
control at each locus. The ChIP process is shown in Figure 9.
If a locus or continuous region of many loci has higher intensity in the IP sample than
the control, it is said to be enriched. The sequences of the enriched regions are analyzed
for the presence of a motif or specific TFBS corresponding to the transcription factor
of interest. Current methods have separated ChIP-chip analysis into two steps that
first identify enriched regions then estimate the TFBS motif given those regions with
a separate procedure. We propose a method that unifies the ChIP-chip and sequence
analyses to more accurately estimate the enrichment probabilities and the location of the
TFBSs.
4.1 The Data
There are two main technologies used for ChIP-chip experiments. First, there is a two-
color system in which the IP sample is labeled with one fluorescent dye and the control
sample is labeled with a different dye and applied to the same array. The probes on the
two-color arrays range from about 100 to 2,000 base pairs in length. For each probe p on
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Figure 9: Chromatin Immunoprecipitation Process as shown in Buck and
Lieb (2004).
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each array, there are two measurements: one for the IP sample intensity (Dye 1) IPp and
one for the control sample intensity (Dye 2) Controlp. The variation due to the random
error of a specific probe’s measurement is reduced by taking the ratio of IPp
Controlp
which
removes the multiplicative effect of probe p that is common to both IPp and Controlp
(Rocke and Durbin, 2001). Enrichment implies that log( IPp
Controlp
) > 0 for a given probe p.
The second type of ChIP-chip is the oligonucleotide array. Oligonucleotide arrays have
probes that are 15-30 base pairs in length and have only one fluorescent sample applied
to each array. For oligonucleotide arrays, the IP sample is applied to one array or set of
arrays, and the control sample is applied to a different array or set of arrays. Enrichment
implies that IPp > Controlp where the two measurements have random errors which
are uncorrelated as the probes are on separate and independent arrays. The two-color
and oligonucleotide enrichment tests are analogous to the paired and unpaired t-test,
respectively.
ChIP-chip analysis should also consider the spatial correlation between probes that
represent adjacent loci. Probes are correlated if the genomic distance between the probes
is less than the length of the DNA fragments in the sample. For example, tiling oligonu-
cleotide arrays have been constructed for human chromosomes 21 and 22 that have an
average inter-probe distance of about 35 bp (Kapranov et al., 2002) (Cawley et al., 2004;
Keles et al., 2004) whereas the distance between the probe midpoints is larger (200-1500
bp) for two-color arrays (Buck and Lieb, 2004). Correlation between adjacent probes is a
prominent feature of the data because the DNA fragments (∼ 1 kb) applied to the arrays
may span two or more probes (Buck and Lieb, 2004).
In this paper, we focus on two-color ChIP-chip data. The ChIP-chip experiment can
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be represented as an P×R matrix Y where microarray replicates are indexed r ∈ [1 . . . R],
and the probes are indexed by p ∈ [1 . . . P ]. A row of this matrix which contains all
measurements from a probe is denoted as Yp. The number of probes P ranges from
10, 000 to 1, 000, 000 in different experiments, and the number of replicates R ranges
from 4 to about 10. Ypr is the log-ratio of the IP sample intensity and the control sample
intensity so that Ypr = log(Redpr/Greenpr). A schematic of the data is shown in Figure
10. The ChIP-chip data consists of consecutive measurements of Y1,1, Y2,1, Y3,1, etc. The
values of Ypr that are higher are more likely to be IP enriched. The histogram of average
values of Yp from the yeast dataset discussed in this paper (Lieb et al., 2001) are shown
in Figure 11. The averages can be thought of as a mixture of the enriched and the not
enriched probes, and the proposed model density estimates for these two components is
shown.
The sequence that corresponds to probe p will be denoted as Xp. The consecutive
probes are complementary to adjacent segments on the genome, and the fragments which
hybridize to the probes correspond to the surrounding sequence. The genome consists
of complementary double helices of DNA, so that each segment of the genome has two
sequences which are the reverse complement to one another. Xp consists of these two
sequences of A’s, C’s, G’s, and T’s with length Kp. The probe sequences can range from
a few hundred to several thousand base pairs in length, but the resolution of each probe
is limited by the size of the applied DNA fragments (about 1000 bp). A subsequence of
Xp from position j to position k will be denoted as Xp[j : k].
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Figure 10: ChIP-chip data schematic is shown for one ChIP-chip replicate.
The genomic sequence is shown in blue, and the segments corresponding to
the probes is indicated by bars over the sequence. The number of base pairs
has been greatly reduced for clarity. Note that log( IPp
Controlp
) is increased for the
probes close to a binding site, and the region corresponding to the significant
probes contains a binding site. Also, note the correlation between adjacent
probes.
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4.2 Current Methods for ChIP-Chip Data
The analysis of ChIP-chip data has been done in two phases. The first phase deals with
the microarray data, and it analyzes the intensity to find the regions of enrichment. The
second phase uses the sequences of the regions found in the first phase to find the motif.
The first analytic phase is discussed below.
4.2.1 ChIP-Chip Analysis to Identify Enriched Regions
The microarray phase of the analysis should consider the spatial correlation between
probes that represent adjacent loci. This correlation occurs when the genomic distance
between the probes is less than the length of the DNA fragments in the sample. There
are a number of methods developed that account for this data feature. First, a sliding
window approach has been suggested by Cawley et al. (2004); Keles et al. (2004); Ji
and Wong (2005). The sliding window methods average the test statistic over adjacent
probes. Cawley et al. (2004) propose using a Wilcoxon rank sum statistic for each probe,
Keles et al. (2004) used Welch t-statistic, and Ji and Wong (2005) used both a t-like-
statistic which has a shrunken variance estimate and a statistic similar to a posterior
probability. These methods identify regions or peaks of intensity as IP enriched when
the moving average of the statistic exceeds a threshold, and should give an FDR or
posterior probability of enrichment for each region. Cawley et al. (2004) only used a
strict p-value cutoff without estimating the FDR. Keles et al. (2004) used a nested-
Bonferroni procedure to estimate the FDR, and suggested cross-validation approach for
choosing the size of the window.
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Ji and Wong (2005) developed a nonparametric method called Unbalanced Mixture
Subtraction (UMS) to estimate the posterior probability and FDR for enrichment. UMS
is a method for estimating a mixture distribution of two components say h(t) = pi0f0(t)+
(1−pi0)f1(t). The parameter pi0 represents the portion of probes or probe moving averages
that are not enriched, and the densities f0(·) and f1(·) correspond to the statistics for
the not enriched and enriched states respectively. UMS requires that one can obtain
estimates for similar mixture densities where one density (g0(t) = p0f0(t) + (1− p0)f1(t))
has a higher contribution from the f0(t) density (p > pi0), and the other density (g1(t) =
q0f0(t)+(1−q0)f1(t)) has a higher contribution from the f1(t) density (q0 < pi0). Another
condition for UMS is that f0(t) ≈ g0(t) or that p0 ≈ 1. Ji and Wong find sets of adjacent
probes to estimate g0(·) and g1(·) by using a cutoff for the test statistic. Given these
densities and the assumption that f0(t)/f1(t) → ∞ as t → t0 for some t0, the authors
show that the component densities f0(·) and f1(·) as well as the mixing proportion pi0 can
be estimated, and from this, the posterior probabilities for enrichment are computed.
Another approach to finding regions of enrichment is to use Hidden Markov Mod-
els (HMM). HMMs are Markov random processes with latent states that emit random
variables whose distributions depend on the state. The HMM naturally incorporates the
spatial dependency in the data because the state of the preceding probe affects the state
of the next probe. The essential components of this HMM are the three states (start,
enriched and not enriched), the parameters describing transition probabilities between
states (pi0, τ0, and τ1), and the emission densities of the probe intensities of the enriched
(f1(·)) and not enriched states (f0(·)). Ji and Wong (2005) used the nonparametric UMS
method to estimate the emission densities and the transition probabilities from the start
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state. The other transition probabilities were derived using approximations, but were not
fit by maximizing the HMM likelihood. Li et al. (2005) implemented an HMM with the
same state space, but used normally distributed parametric models for the emission den-
sities. The emission from an IP enriched state had a mean that was 2 standard deviations
above the control mean, and the transition probabilities for changing between enriched
and not enriched states were the same for both states and fixed before fitting the model.
Li et al. (2005) and Ji and Wong (2005) both demonstrate the superior performance of
the HMM method over moving average models in terms of power for detecting IP en-
richment for small sample sizes. The HMMs were not compared against each other. One
problem with both of these methods is that the transition probabilities and the emission
densities are not estimated simultaneously by the HMM.
Keles (2006) proposed a hierarchical mixture model for detecting regions of IP en-
richment. The model is similar to that of the Bayesian method for differential expression
of Kendziorski et al. (2003) and closely related to the parametric model of Newton et al.
(2004a) in that the probe intensities have mixture distributions which have parametric
components corresponding to null and alternative hypotheses. The model divides the
genome into N continuous regions Ri (i ∈ 1 . . . N), and each region contains Li adjacent
probes. The array data consists of the control j th probe intensity (j ∈ 1 . . . Li) for the
ith region Xj(i) and the corresponding IP sample intensity Yj(i). The latent means of
Xj(i) and Yj(i) are µj1(i) and µj2(i) respectively. This model estimates the posterior
probability that a region contains one and only one subregion of IP enrichment or peak
as an expectation of a latent indicator variable Ri. The existence of the peak (Ri = 1)
implies that µj1(i) ≤ µj2(i), and µj1(i) = µj2(i) if there is no peak (Ri = 0). The bound-
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aries of the peaks have posterior distributions that are estimated by the model. The start
position is given by Zi and the end position is Vi. Zi and Vi are discrete random variables
that take values corresponding to the probes in the region, and wi is the random variable
for the length of the peak in terms of numbers of spanned probes so that wi = Zi−Vi +1.
The posterior distribution of Zi and Vi for enriched regions is the important indication
of the localization of enrichment within a region. Keles proposes a parametric density
for the latent means of the probe intensities, and uses conjugate gamma distributions for
the probe intensities themselves. The conjugate intensity distributions are vital to the
model because the latent means of the probes are integrated out analytically. The EM
algorithm is used to fit the model, and Keles reports that there may be multiple station-
ary points. Keles also shows that the estimates for the FDR may be anticonservative
when the error model is grossly misspecified. However, the author demonstrates that the
hierarchical model has superior power for small sample sizes compared to sliding window
methods.
The previous methods for ChIP-chip analysis identify the enriched regions of the
genome, but the next analytical phase in the two step approach examines these enriched
regions and estimates the motif patterns within them. These methods are discussed in
the next section.
4.2.2 Sequence Analysis of Enriched Regions
The TFBS discovery within the sequences of the enriched regions is statistically chal-
lenging for many reasons. A transcription factor binding motif is not an exact sequence,
and it is usually represented by a 4× w position specific weight matrix (PSWM) Θ that
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defines a product multinomial distribution where the four rows represent the nucleotides
A, C, G and T and the w columns represent the w motif positions (Liu et al., 1995).
The element Θij is the probability that the nucleotide at position j of the sequence is i,
i = {A,C,G, T}. Searching for patterns of several base pairs within segments of DNA
that might be several thousand base pairs long can lead to many false positive matches
because there are thousands of potentially similar sites within a single DNA segment.
This multiplicity greatly increases the computational burden, especially if many different
DNA segments are considered simultaneously. Further, the “background” DNA sequence
that does not contain binding sites generally has a highly non-random distribution of nu-
cleotides, for instance, it may contain dependencies between consecutive base pairs, and
these patterns can mimic motifs. The computational and statistical challenges of motif
discovery have led to the development of a number of statistical model-based methods for
motif discovery (Bailey and Elkan, 1994; Lawrence et al., 1993; Liu et al., 1995; Gupta
and Liu, 2003; Thompson et al., 2004; Zhou and Liu, 2004; Gupta and Liu, 2005; Shida,
2006) as well as computationally fast and partially heuristic methods (Liu et al., 2001,
2002; Buhler and Tompa, 2002; Keles et al., 2002; Sinha et al., 2004; Elemento and
Tavazoie, 2005).
4.2.3 Motivation for a Unified Model
The key difficulties of the two step approach are displayed in Table 11. The first stage
categorizes the probes into the columns (Enriched/Not Enriched), and the second stage
categorizes the probes sequence into the rows (Binding Site/No Binding Site). The first
stage might be considered as a screening test for probes, whereas the second stage is
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Table 11: Different Possible Probe Outcomes
Probe Intensity
IP Enriched Not Enriched
Probe Binding True Ambiguous
Sequence Site Positives False Neg?
Contains No Binding Ambiguous True
Site False Pos? Negatives
similar to a confirmatory test for a probe containing a TFBS. In this case, the diagonal
quadrants of the table would consist of the probes that were accurately classified by the
first stage where the left upper quadrant represents the true positives, and the right lower
quadrant the true negatives, although only the probe sequences classified as enriched
typically are searched for a TFBS. The off-diagonals represent ambiguous states in which
probes could have been falsely identified as either enriched or not enriched. Another
possibility for probes falling into the off-diagonal categories is that there is underlying
biological complexity not explained by the simple binding model, as discussed further
in Section 4.6. Minimizing the number of probes that fall in the off-diagonal quadrants
is the primary motivation for a model the considers the probe sequence and the probe
intensity measurements simultaneously.
Another theoretical advantage of the joint model is the more accurate estimation of
the binding site probabilities. In the two step approach, the first step estimates the
enrichment probabilities P (E) and selects sequences based upon this probability. The
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second step estimates the binding site probabilities P (B|E) within those sequences taken
to be enriched with a completely different model. However, the second step could ignore
the uncertainty in selecting the sequence in determining P (B|E). The proposed method
estimates the enrichment and the binding sites simultaneously which yields an estimate
of the joint probability P (B ∩ E) that takes into account both sources of uncertainty.
The organization of the rest of the paper is as follows. Section 4.3 describes the
proposed model. Section 4.4 discusses a set of simulation studies, and Section 4.5 contains
an analysis of a yeast ChIP-chip experiment for the Rap1 TF (Lieb et al., 2001). Section
4.6 contains a discussion of the overall results and outline future avenues of research.
4.3 The General Model
In this section, we first describe the models used for the probe intensity, the probe
sequences, and the joint HMM framework for the probe intensity and sequence data.
4.3.1 Probe Intensity Model
The probe level data is modeled through a hidden Markov model (HMM). HMMs are
defined by the latent or hidden states, the emission densities of the states, and the
transition probabilities between these states. The hidden states of the HMM at the probe
level are the binding states of probe p denoted as sp where sp = 1 if the p
th probe is IP
enriched and sp = 0 otherwise. The intensity emission has density fsp(Yp) where f0(Yp)
is the not enriched density and f1(Yp) is the enriched density for the p
th probe’s intensity
vector Yp. We assume a hierarchical model such that the measurements for a probe Yp
will be a vector of replicate observations related by a probe-specific mean µp, and the
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rth replicates Ypr are conditionally independent given µp so that Ypr|µp, σ
2
a ∼ N(µp, σ
2
a).
This density for Ypr is denoted as fobs(·). The normality assumption is justifiable if
one considers the raw intensity values to have a gamma distribution that is close to a
lognormal distribution so that the log transformation yields an approximately normal
random variable. The distribution for µp is defined in the next layer of the hierarchy to
be µp|sp = 0 ∼ N(0, τ
2
0 ) and µp|sp = 1 ∼ N(µ1, τ
2
1 ). We denote these priors for µp as
pisp(·). Figure 11 demonstrates that the observed probe averages Y¯p may be accurately
fit by the proposed mixture normal densities for µp. The density for Yp can be written
as fsp(Yp) =
∫ ∏R
r=1 fobs(ypr|µp, σ
2
a)pisp(µp)dµp. Integration with respect to the parameter
µp yields a compound symmetric multivariate Gaussian density for Yp with mean spµ11R
and covariance matrix σ2aIR + τ
2
sp1R1
′
R where 1R is a vector of 1’s of length R and IR is
the identity matrix with dimension R.
4.3.2 Sequence Model
The vast majority of the DNA that is not within the binding sites of interest is referred to
as the background DNA sequence. Subsequent letters of this background sequence have
some dependency on the previous letters. By accounting for dependencies between the
adjacent positions of the background sequence, one hopes to more accurately estimate the
foreground motif. This dependency is often modeled as having a higher order Markov
structure (Liu et al., 2002). However, these Markov models require large numbers of
parameters, and some dependencies such as simple repeats are more important than oth-
ers for distinguishing binding site motifs from background patterns. We propose using
PSWMs representing repeats to allow for the modeling of these low complexity back-
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ground patterns with fewer parameters than Markov models. Specifically, the PSWMs
of the proposed background model include one-letter words (A, C, G, and T) as well as
repeats of A’s and T’s.
Next, we formulate the model for the sequence data in detail. PSWMs in the model
will be denoted as Θv ≡ where v ∈ [1 . . . V ], and ΘV ≡ is the motif corresponding to the
transcription factor of interest. Let Θv have length wv, and let piv be the prevalence of
PSWM v. The emission densities of the sequence are p0(Xp) and p1(Xp) for the enriched
and not enriched states, respectively. The density p0(Xp) denotes p(Xp|Θ1, ..,ΘV −1), the
likelihood of observing the sequence Xp given that it was produced by the background set
of PSWMs Θ1, ..,ΘV −1. Similarly, p1(Xp) ≡ p(Xp|Θ1, ..,ΘV ) denotes the same likelihood
given that the motif of interest ΘV could be present in the set of PSWMs generating the
sequence. The sets of PSWMs in p1(Xp) and p0(Xp) can be considered as words that are
part of a stochastic dictionary (Gupta and Liu, 2003).
The sequence likelihoods p0(Xp) and p1(Xp) do not have closed forms and can be
calculated using a recursive formula. The likelihood of subsequence Xp[i : j] given that
it was emitted from motif Θv is denoted as p(Xp[i : j]|Θv) where j − i + 1 = wv and is
given by
p(Xp[i− wv + 1 : i]|Θv) = I[i− wv + 1 > 0]I[i ≤ K]
i∏
j=i−wv+1
∏
l∈{A,C,G,T}
Θ
I[Xp[j]=l]
v,lj .
The term I[i−wv +1 > 0]I[i ≤ Kp] makes the probability 0 when the motif would not fit
within the sequence. p1(Xp) are calculated by using a recursive summation involving the
terms φp(k) which are the probabilities of Xp up to position k allowing for all possible
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motif sites as below
φp(k) = p1(Xp[1 : k])
=
V∑
v=1
pivp(Xp[k − wv + 1 : k]|Θv)φp(k − wv). (58)
p0(Xp) is found similarly by allowing v = 1, .., V − 1.
4.3.3 The HMM Likelihood
Hidden Markov model likelihoods generally cannot be written in a closed form so that
a recursive procedure based upon the law of total probability are used in the likelihood
computation (Juang and Rabiner, 1991). We use a forward summation recursive formula
for computing the likelihood of an HMM, described below. We define gp(s), the forward
probability of state s at probe p, as the probability of the sequence of probes up to probe
p given that the pth state is s, given by
gp(s) = P (Xp, Yp|s)
∑
sp−1∈{0,1}
gp−1(sp−1)τsp−1,s (59)
where P (Xp, Yp|s) = ps(Xp)fs(Yp) for s ∈ {0, 1}. The states {−1, 0, 1} respectively
correspond to the start, not enriched, and enriched states. The τij parameters represent
the transition probability i → j. The likelihood quantities gp(s) in (59) will be used to
draw samples of probe states sp within the data augmentation method for fitting the
model, described further in Section 4.3.5. Prior specification for the joint intensity and
sequence HMM is discussed in the following section.
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4.3.4 Priors
The priors for the intensity parameters µ1 were taken to be noninformative (∝ 1), and
τ 20 , τ
2
1 , σ
2
a were also take to be noninformative, in other words, p(τ
2
0 ) ∝ τ
−2
0 , p(τ
2
1 ) ∝ τ
−2
1 ,
and p(σ2a) ∝ σ
−2
a . The priors for each row of the HMM transition matrix (τij) (i, j =
−1, 0, 1) are taken to be Dirichlet distributions with hyperparameters denoted as δij.
More precisely, [τsi0, τsi1] ∼ Dirichlet(δi0, δi1). The δij are equal for all transitions so that
δij = δi′j′ and are small (0.1) relative to the total number of transitions ∼ P = 11, 575,
and therefore, minimally informative.
One difficulty in estimating the motif is that the motif and prevalence of the motif may
be jointly nonidentifiable in practice. The less conserved a motif is, the more prevalent it
may be. If there is no prior placed on the motif prevalence, then the model often tends
to converge to a highly prevalent and non-specific motif which contradicts the biological
understanding of the specificity of transcription factor binding. A relatively strong prior
may be implemented for piV to avoid this problem and hasten convergence. Instead of
drawing the PSWM prevalence vector pi from a Dirichlet distribution, the vector of piv can
be drawn in a hierarchical manner. The prior for the transcription factor motif prevalence
is piV ∼ Beta(δ0(1 − γ), δ0γ) where δ0 is a large pseudocount and γ (with 0 < γ < 1)
indicates the prior expected value. The conditional prior for the other components of
pi (pi1, . . . , piV −1) can then be drawn from the prior Dirichlet distribution D(δ1, .., δV −1)
and scaled by 1− piV . δ1, .., δV −1 represent pseudocounts which are set to a small value
to avoid Dirichlet parameters of value 0. The prior for the motif matrix of interest ΘV
is taken to be the product Dirichlet distribution PD(B) where B is a 4 × wV matrix
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of pseudocounts where the element Bij is the count of the symbol i at motif position
j which is set to a small value to avoid Dirichlet parameters of value 0, but is uniform
across letters and not informative. The Data Augmentation (DA) sampling scheme for
fitting the full HMM is given in the following section.
4.3.5 MCMC Fitting Procedure
We fit the model with a Data Augmentation (DA) method. The complete steps of the
algorithm are given in the Appendix. First, all the model parameters µ1, τ
2
1 , τ
2
0 , σ
2
a,
Θv, pi, τij, and s1, . . . sP are initialized. The intensity parameters (µ1, τ
2
1 , τ
2
0 , σ
2
a) are
sampled using a Metropolis-Hastings (MH) random walk procedure, and the enrichment
states sp are then sampled jointly using the backward sampling technique described in
Section 4.3.3. The transition parameters τij can be drawn from the complete conditional
distribution Beta(tij + δij,
∑
k 6=j tik + δij) where tij are the i→ j transitions.
Backward sampling generates samples from the joint complete conditional distribution
of the vector of sp. The probability distributions for sP , sP−1 . . . s1 are given by
sP ∼ Bern
(
gP (1)
gP (1) + gP (0)
)
, (60)
and for p ∈ {1, . . . , P − 1}
sp ∼ Bern
(
gp(1)τ1,sp+1
gp(1)τ1,sp+1 + gp(0)τ0,sp+1
)
. (61)
The sp imply a segmentation of the entire genomic sequence into enriched regions with
sp = 1 and not enriched regions with sp = 0. The enriched segments are formed by
the overlapping regions of the genome that correspond to probes with sp = 1, and these
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segments are denoted by Xe with length Ke where the index e (e ∈ {1 . . . ne}) stands for
Enriched segment.
Another DA algorithm is applied to the Xe in order to sample the motif matrix ΘV .
We define the Ke × V matrices Ae corresponding to the segments Xe. The elements
Ae,jv indicate the sampling of the motif or PSWM v at position j such that Ae,jv = 1 iff
the vth PSWM was sampled with Ae,jv = 0 otherwise. We may sample Ae,jv using the
backward algorithm described in the Appendix. The motif matrix ΘV depends on the
letter counts from the sampled TFBS where Ae,jV = 1, and we will call this 4×wV count
matrix C where the element Cij is the number of the symbol i at motif position j. ΘV
has conditional distribution PD(B+C) where PD is the product Dirichlet distribution.
Next, the pi parameter depends on the number of sampled realizations of each PSWM
n1, .., nV given by Ae so that piV ∼ Beta(δ0(1−γ)+
∑V −1
v=1 nv, δ0γ+nV ), and the complete
conditional for [pi1, . . . , piV −1] becomes Dirichlet(n1 + δ1, .., nV −1 + δV −1).
4.4 Simulation Study
A simulation study was performed to assess the model performance when the true loca-
tions of the binding sites are known. The datasets were generated in two ways. First,
the sequence was simulated based upon the proposed probe intensity model. Second, the
sequence was simulated based upon the TileMap nonparametric ChIP-chip model of Ji
and Wong (2005), introduced in Section 4.2.1.
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4.4.1 Data Generation
Simulated datasets were generated to assess the operating characteristics of the proposed
method compared to the intensity only HMM and the TileMap HMM. The real intensity
data was used instead of simulated intensity data in order to mimic the structure and the
informativeness of the true experiment. To simulate the sequence data, we used the probe
intensity data from the Rap1 dataset (Lieb et al., 2001) with four independent arrays
described in Section 4.5, and we applied the intensity only model and the TileMap model
which gave the probe enrichment probability estimate sˆp. The enrichment state for each of
the probes were then simulated by Bernoulli random variables with probability sˆp, that is,
sp,Simulated ∼ Bernoulli(sˆp). For the probes that were selected as enriched (sp,Simulated = 1),
motif realizations were randomly inserted into the corresponding genomic sequences.
4.4.2 Analysis of Simulated Data
The accuracy of the binding site estimates is used to assess the models. The proposed
joint intensity-sequence (IS) model gives the binding site probabilities directly, but the
two step ChIP-chip methods like TileMap (TM) give only the enrichment probabilities
of the probe sequences, not specific binding sites within those sequences. In order to get
binding site estimates, we used the following two step procedure. If a probe sequence
had a posterior probability > 0.5 for enrichment, then it was included in the set of
selected sequences. These selected sequences were searched for binding sites by fitting the
stochastic dictionary model. The primary aim of the analysis is to locate the binding sites
of the transcription factor, and these sites may be estimated by the posterior probability
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that each position on the genome corresponds to a sampled motif binding site such
that Ae,jV = 1. This probability is estimated by averaging the indicators Ae,jV at each
position on the genome at each iteration of the DA sampler. A position on the genome
was included in a list of binding sites if the posterior probability of being sampled as a
TFBS was > 0.5.
When fitting motif discovery models with real DNA used as background, there are
multiple motifs that represent multiple modes in the likelihood surface which may result
in poor convergence. Multimodality issues when one does not know the true motif are
discussed in the Section 4.5. For the simulations, the DA sampler was initialized to the
true motif estimate and then updated as per the algorithm. This is done to limit the
amount of human supervision that would have been required for de novo motif finding
within the many simulated datasets. In the low prevalence scenarios, a strong prior was
placed on the prevalence of the motif to prevent divergence as described in the Section
4.3.4 so that δ0 = 10
6 and γ = 0.0001. Sensitivity analyses demonstrated that model
estimation was robust to prior specifications within a moderately large range of the set
values (more details in Section 4.5).
Four models were applied to each dataset. In the first model, the motif sites were
sampled with the stochastic dictionary model conditioning upon the true enrichment re-
gion. Call this the Known Binding Region (KBR) model. Second, the two step procedure
was applied by fitting the Intensity Only (IO) model, and third, the two step procedure
was applied using the TileMap method (TM). The TileMap method was not originally
designed for two-color arrays, but it is flexible and may use a test statistic for probe en-
richment computed by another method. The test statistics for each probe were computed
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separately as the p-value under the null hypothesis that Y¯p ∼ N(0, τˆ
2
0 + σ
2
p/R) where τˆ
2
0
is given by the IO model, and σ2p is a shrinkage estimate for the variance suggested by Ji
and Wong (2005). Lastly, the proposed joint intensity and sequence (IS) model was ap-
plied. The model performance assessment was in the sensitivity and Positive Predictive
Value (PPV) for detection of simulated binding sites.
4.4.3 Intensity Only Model Simulations
The first step was to fit the intensity only model to the array data which results in
enrichment estimates sˆp from which the enrichment probes are selected as described in
Section 4.4.1. There were four simulation scenarios with two levels of motif conservation,
and two levels of motif site prevalence. The two simulated motifs were a highly conserved
motif and the Rap1 binding motif taken from the literature. The highly conserved motif
consisted of a 13 length sequence with each position having a 99% probability of the
consensus letter and the rest of the letters with equal probability. The two levels of motif
prevalence were 0.0005 (High) and 0.0002 (Low). Each of the four scenarios was repeated
5 times. The results are shown in Table 12.
As one might expect, the highly conserved motif was detected more accurately than
the Rap1 motif for all models. Also, the decreasing the prevalence of the Rap1 motif
negatively impacted the sensitivities of all models. However, the effects of motif conser-
vation were the most profound. The IS model was almost equivalent to the KBR model
with the artificial motif. The IS model gives superior performance compared with the
IO model in terms of both sensitivity and specificity for all four scenarios. Most notably,
the PPV is enhanced by the joint IS model for all scenarios from ∼ 65 for the IO model
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Table 12:
Simulations Based on Intensity Model Enrichment Estimates
KBR = Known Binding Region; IO = Intensity Only Model;
IS = Joint Intensity Sequence Model; TM = TileMap Model
Table 2a - Highly Conserved Motif and Prevalence = 0.0005
Outcome (SD) True KBR IO TM IS
Sensitivity - 91.8 (1.2) 77.7 (1.4) 37.6 (1.2) 90.1 (1.0)
PPV - 93.5 (6.5) 63.4 (1.3) 63.2 (0.6) 93.2 (0.8)
Total Sites 839 (31) 821 (31) 1016 (57) 505 (23) 829 (30)
Table 2b - Highly Conserved Motif and Prevalence = 0.0002
Outcome (SD) True KBR IO TM IS
Sensitivity - 91.9 (2.0) 78.8 (3.2) 37.5 (1.2) 91.4 (2.6)
PPV - 93.2 (1.3) 62.5 (1.5) 62.1 (0.9) 92.9 (1.7)
Total Sites 336(21) 331 (22) 423 (29) 209 (13) 331 (24)
Table 2c - Rap1 Motif and Prevalence = 0.0005
Outcome (SD) True KBR IO TM IS
Sensitivity - 70.5 (1.3) 57.7 (1.7) 23.4 (1.8) 63.7 (1.5)
PPV - 95.7 (0.5) 63.4 (0.9) 66.7 (0.3) 97.2 (1.0)
Total Sites 868(21) 639 (24) 790 (21) 306 (33) 569 (14)
Table 2d - Rap1 Motif and Prevalence = 0.0002
Outcome (SD) True KBR IO TM IS
Sensitivity - 57.2 (4.2) 41.7 (3.0) 7.9 (8.9) 45.5(5.0)
PPV - 95.3 (2.2) 67.3 (1.8) 33.8 (32.7) 98.2 (1.6)
Total Sites 339 (22) 204 (22) 211 (30) 131 (24) 158 (25)
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compared with ∼ 95 for the IS model. This implies that the motif matrix estimation is
more accurate for the IS because this estimation is directly related to the accuracy of
binding site estimation. In the low prevalence Rap1 motif scenario, TileMap procedure
failed to find any binding sites in 2 of the 5 simulations.
4.4.4 Simulated Sequence Based on the TileMap Model
Next, we simulated sequences based upon the nonparametric TileMap intensity model
enrichment estimates. The TileMap intensity model selected fewer regions to be enriched
than the intensity only model, and a higher prevalence of binding sites within these
regions was needed in order to estimate the motif accurately. The Rap1 motif was
randomly inserted into the selected regions with a prevalence of 0.001. This scenario
was repeated 5 times, and the results are shown in Table 13. The TileMap (TM) model
has the highest sensitivity of the three models, but the joint IS model is demonstrated
to have superior PPV compared to the TM model (98% vs 67%) with little penalty in
terms of lost sensitivity (56% vs 64%). The nonparametric intensity model of TileMap
assumes that the probe intensity component of the proposed model may be misspecified,
but the proposed joint model still shows an excellent performance.
4.5 Yeast Data Case Study
We considered a yeast dataset from Lieb et al. (2001) which was a ChIP-chip experiment
for the Rap1 transcription factor.
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Table 13:
Simulations Based on TileMap Enrichment Estimates
KBR = Known Binding Region; IO = Intensity Only Model;
IS = Joint Intensity Sequence Model; TM = TileMap Model
Prevalence = 0.001
Outcome (SD) True KBR IO TM IS
Sensitivity - 77.5 (0.9) 55.9 (2.0) 63.9 (2.1) 56.3 (2.2)
PPV - 93.3 (1.0) 70.0 (1.6) 67.1 (1.0) 98.3 (0.8)
Total Sites 656 (33) 595 (22) 566 (33) 623 (40) 391 (21)
4.5.1 Data Preprocessing and Initialization
The data consist of four arrays and 11, 575 non-telomeric probes of various lengths span-
ning the yeast genome of 17 chromosomes with a total of 12 million base pairs. Simple
repeats were removed from the genome with the RepeatMasker software (Smit et al.,
2004). We used median centering and variance standardization to normalize the data.
Shifting the median of each array to 0 is important because the proposed model assumes
that the majority of the observations will arise from a distribution that is symmetric
about 0. The model also assumes that the within array variance is equal which moti-
vates variance standardization. This procedure produced good results as seen later in
this section, but there is still a need for improved normalization methods designed for
ChIP-chip data (Buck and Lieb, 2004).
We preprocessed the data through an initialization phase that is similar to the first
step of the two stage procedure in which the segments of highest enrichment are selected
using the intensity only model. This step will allow the model to avoid the multimodality
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difficulties of sequence modeling by providing the initial estimate of the motif matrix that
will later be updated by the joint model. These probes that were selected by the IO model
were ranked according to the log-ratio of the intensity probabilities in favor of enrichment
log(f1(Yp)/f0(Yp)). The sequences of the probes in the highest 1% likelihood ratios were
then selected, and the following search for the initial motif estimate was implemented.
The initialization of the sequence model requires a reasonable estimate of the TFBS
motif to facilitate convergence. The sequences selected by the above procedure are likely
to have the highest concentration of the binding site for the motif, but it is evident that
there are many non-random patterns in the DNA that correspond to different modes in
the likelihood and can lead to the failure of the stochastic dictionary model to find the
motif which gives the highest likelihood for these sequences.
An accumulating stochastic dictionary model was fit to the sequences in which suc-
cessive motifs are estimated and then added to the dictionary which accumulates these
new motifs. First, the dictionary was initialized with PSWM of length one representing
A’s, C’s, G’s, and T’s as well as repeat words of A’s and T’s of both of length 4 and
length 8. These 8 motifs were considered part of the fixed background model with motif
matrices Θ1, . . .Θ8. The search was restricted to the previously reported motif width of
13 (Lieb et al., 2001), and a motif of length 13 with uniform probability across all letters
at all positions was added to the dictionary and updated using the data augmentation
method described in the Section 4.3 (V = 9). The prevalence of this motif is fixed to
be 0.0001, and this motif is considered the foreground motif Θ∗ and is the only motif
updated in each cycle of the DA sampler. After approximate convergence, the updated
motif is added to the fixed background dictionary, and another motif of length 13 with
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uniform probability across all letters at all positions is added to the dictionary so that
V = 10, and this new word becomes the new updated foreground motif. The procedure of
iteratively adding words to the background allows the model to consider different modes
in the space of potential motifs.
Two likelihoods of the sequences are plotted across the iterations in order to find a
reasonable motif for initialization. The first is the likelihood of the sequences given the full
dictionary up to that point which may be denoted as
∏
Xi∈Top Sequence
p(Xi|Θ1, . . .Θ8+m,Θ
∗)
where m ≥ 1 is the number of accumulated words and Θ∗ is the updated motif. The
recursive relationship (58) is used to calculate the likelihood of the stochastic dictionary.
The likelihood generally increases as motifs are added to the dictionary, and after a few
iterations a plateau is reached signifying entrapment in a likelihood mode. The second
likelihood computed is based on the original eight-PSWM background with only the cur-
rent foreground motif and may be denoted as
∏
Xi∈Top Sequence
p(Xi|Θ1, . . .Θ8,Θ
∗). This
likelihood is an indication of the improvement in model fit given the addition of only the
current foreground motif. These two plots are shown in Figure 12 for 4 runs of length
2000 in which a total of 8 words are added to the dictionary every 250 iterations. One
can see that runs 2 and 3 have the highest likelihood and that the fifth motifs added
in both of the runs give the largest improvement in model fit. The fifth motifs added
in both of these runs are very similar. The final estimate for the Rap1 shown in Figure
13 as well as the initialization motif, and there is a strong resemblance to the motifs
reported previously by (Lieb et al., 2001) and in the TRANSFAC database (Matys et al.,
2003). We conclude that the motif that gives the largest increase in sequence likelihood
is a reasonable choice for the initial estimate in the joint sequence and intensity model.
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The next phase of the analysis is the application of the joint model. An assessment of
the sensitivity to the selection of hyperparameters was performed as well as a comparison
of the results with other ChIP-chip methods in the next section.
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Figure 12: Likelihood trace plots for Accumulating Dictionary (Upper), and
Single Word Addition (Lower). Independent runs are distinguished by bold
vertical bars, and subsequent motifs are separated by light vertical bars. The
Rap1 motif is discovered as the fifth motif in runs 2 and 3.
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Figure 13: Comparison of motif logos of the model estimates and literature.
The final motif estimate for Rap1 by the joint IS model is at the top. Second
from the top is the initial estimate given by the accumulating dictionary. The
bottom two plots show the motif discovered by Lieb et al. (2001) and the
motif listed in the TRANSFAC database.
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4.5.2 Sensitivity Analysis
The next phase of the analysis is the application of the joint model. An assessment of the
sensitivity to the selection of hyperparameters was performed as well as a comparison of
the results with other ChIP-chip methods.
We first did a sensitivity analysis to examine the dependence of the final estimates on
the choice of the prior hyperparameters. The hyperparameters for the pseudocounts δ0ij ,
δv, and the elements of the pseudocount matrix B were set to 0.1. These pseudocounts
are quite small compared to the number of observed counts, and do not greatly affect
inferences. We fixed δ0 = 10
6 and varied the prior parameter for the expected motif
prevalence γ ∈ {5.0×10−5, 6.0×10−5, 7.0×10−5, 8.0×10−5, 9.0×10−5, 10.0×10−5, 20.0×
20−5} to assess the sensitivity to this prior. To initialize the IS model, the IO model
DA sampler was repeated for 1, 000 iterations for a burn-in period, and the parameter
estimates from the 1, 000th iterations were used as the initial values for the IS model.
The IS model DA sampler was repeated for 1, 000 more iterations, and the last 750 were
sampled for posterior inference. MCMC convergence of the DA sampler was diagnosed
with parallel chains by using the Gelman and Rubin
√
Rˆ statistic. The joint IS model
was then applied and the corresponding number of binding sites found for each value of
γ were {278, 290, 293, 297, 306, 311, > 1000} respectively. The last value indicated that
the model did not converge to the correct mode of the posterior distribution. One can
see that the number of TFBSs was about 300 in the range γ ∈ [7.0× 10−5, 10.0× 10−5].
The positions of the binding sites discovered were also very consistent, the intersection
of the binding site lists for each consecutive value of γ being {277, 287, 291, 297, 303,−}.
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In other words, all 277 of the 278 TFBSs found when γ = 5.0 × 10−5 were also found
when γ = 6.0× 10−5.
4.5.3 Comparisons with Other Methods
We chose the largest value of γ = 10−4 for which convergence was observed to compare
the IS method with three two step methods. The first method is the intensity only
(IO) model which is the proposed method without the sequence component, the second
method is the Chipotle method (Buck et al., 2005), and the third method is TileMap (Ji
and Wong, 2005). The Chipotle method requires that one choose a normal approximation
or a nonparametric model to estimate the p-value for rejection of the “No Enrichment”
null hypothesis, and one must decide on a p-value cutoff for selecting regions for the motif
finding stage. We chose the normal approximation method and a p-value cutoff of 0.001.
There does not seem to be an objective rule for choosing this cutoff, but this conservative
value is consistent with our other models.
These three methods were implemented, and they produced estimates of the regions
of IP enrichment to which the stochastic dictionary model was applied with γ = 10−4
and δ0 = 10
6 to obtain lists of estimated TFBS as in Section 4.4.2. The estimates for
the parameters common to the IO and the IS models are shown in Table 14, and these
estimates are quite similar for all parameters. The comparisons of estimated TFBS are
shown in Table 15. There is marked agreement between the three methods with the IS
model finding the most TFBS and the IO model the next to most. However, the TileMap
method found roughly half of the TFBS of the other methods. The TFBS found by the
joint IS model included 97.5%, 89.9%, and 96.9% of the TFBS found by the IO model,
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Table 14:
Parameter Estimates from IO and IS methods
Parameter Intensity Only Intensity with Sequence
Estimate (SD) Estimate (SD)
µ1 0.982 (0.03 ) 1.01 (0.03 )
σa 0.1172 (0.001) 0.1172 (0.001)
τ 20 0.045 (0.001) 0.045 (0.001)
τ 21 0.364 (0.021) 0.346 (0.020)
τ00 0.97 (0.002) 0.97 (0.002)
τ11 0.71 (0.02 ) 0.70 (0.02 )
Chipotle, and TileMap respectively. Also, the IS model was highly consistent in that it
found a much larger number of sites compared to TileMap, for example, that found only
52.8% of the Chipotle sites. This might indicate a higher sensitivity of the IS model,
but the higher specificity cannot be directly assessed because the locations of all “true”
binding sites are not known.
An analysis of the differences between the probe enrichment probabilities estimated
by the IO model and the joint IS model was performed to examine the effect of adding the
sequence component to the model. Figure 14 shows the posterior probability P (sp = 1|D)
of probe enrichment under the IO and IS models for all of the probes. Most of the
posterior probabilities are close to 0 with a smaller cluster of probabilities close to 1.
This polarity of probabilities motivates the cutoff of P (sp = 1|D) > 0.5 for selecting
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Table 15: Estimated Binding Site Comparisons of Four Methods
- TileMap Chipotle Intensity Only Intensity with Sequence
TileMap 163
Chipotle 141 267
Intensity Only 156 235 287
Intensity with Sequence 158 240 280 305
probes as enriched. The enrichment probabilities for the probes that were identified as
enriched by one model and not the other in quadrants A (IS only) and D (IO only) have
IO model enrichment probabilities in the range [0.049, 0.746]. These probes are neither
definitely enriched nor definitely not enriched according to the IO model. The probes
above the diagonal x = y have joint IS model enrichment probabilities that were higher
than the enrichment probabilities based upon intensity alone. Most of the probes have
smaller enrichment probabilities under the joint IS model. The IO model selected 934
probes as enriched while the IS model selected 922 probes as enriched. Even though
fewer probes were identified as enriched by the joint IS model, the IS model found more
binding sites which is consistent with the IS model selecting probes that are more likely
to correspond to binding sites. These data are also consistent with the idea that including
sequence in the model can help to classify some of the probes with ambiguous posterior
enrichment probabilities so that more probes corresponding to binding sites are identified
as enriched.
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Figure 14: Posterior probabilities for probe enrichment under the Intensity
Only (IO) model and Joint (IS) model for all 11,575 probes. The plot has
been divided into four quadrants A-D by the lines x = 0.5 and y = 0.5. The
unit line x = y is also drawn. The polarity of the probabilities is evident in
the clusters of values at 0 and 1. Probes above the diagonal have enrichment
probabilities higher under the IS model, and probes below the diagonal have
enrichment probabilities greater under the IO model. The C quadrant contains
probes that the IS and the IO model both declared to be not enriched (10,605),
and quadrant B contains the probes selected by both models to be enriched
(886) The D quadrant contains those probes identified as enriched by the IO
model, but not the joint Intensity Sequence (IS) model (48). The A quadrant
contains those probes identified as enriched by the IS, but not the IO model
(36).
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4.6 Discussion
The proposed HMM for transcription binding site detection in ChIP-chip experiments was
motivated by the HMMs of Ji and Wong (2005) and Li et al. (2005) with the important
extension of jointly analyzing the sequence data rather than the implementation of a two
stage procedure. A sequence likelihood based on a stochastic dictionary model is included
the emission densities of the HMM. The joint Intensity Sequence (IS) model was shown
to significantly out-perform the two stage procedure for binding site discovery in terms of
the sensitivity and especially the specificity in the simulated data. The IS model was also
applied to a yeast dataset which examined the DNA binding of the Rap1 transcription
factor. We proposed a method for overcoming the multimodality difficulties of de novo
motif discovery using an accumulating stochastic dictionary and choosing the motif that
gave the greatest increase in the sequence likelihood. The resulting de novo motif estimate
is in close agreement with the Rap1 motif found in the literature. The binding sites
estimated by the proposed method from the experimental data were compared to the the
binding estimates of the intensity only model, the Chipotle method, and the TileMap
method. It is important to note that these three methods do not yield the binding sites
directly, but the stochastic dictionary model had to be applied in the second stage. This
shortcoming of intensity only models strains comparisons with the IS method because
these comparisons would overlook the additional utility of the IS indicating the posterior
probability of an exact position (1 base pair) on the genome of a binding site rather than
merely estimating the posterior probability that a region (100-2000 base pairs) might
contain one or more binding sites. This utility of the joint model may be considered a
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large improvement in resolution in binding site discovery. Nevertheless, the binding sites
found by the IS and the two stage approaches were mostly identical, but the IS model
estimated the largest number of binding sites. Simulation studies indicated that the joint
IS model can successfully estimate binding site probabilities with much higher specificity
than two step ChIP-chip analyses that might not accurately combine the uncertainty of
enrichment region selection and the uncertainty of binding site identification.
Future work would include several possible variations and extensions of the IS model.
First, the IS model currently assumes that each of the large and possibly overlapping
sequences corresponding to the probe measurements are either enriched or not enriched.
However, with the increasing availability of data at higher resolution, an alternative
method might consider modeling smaller non-overlapping segments of DNA having a
latent enriched or not enriched state. This might allow for higher resolution, and is
another way of pooling the intensity information for adjacent probes. Second, the simple
binding model of Table 11 is a reductionist perspective of the transcription factor binding
process. The sequence model could be extended to include the possibility of alternative
binding motifs for the transcription factor of interest. Alternative motifs could account
for some of the probe enrichment not due to the primary motif of interest. Also, the
latent state space could be extended from two state (enriched or not) to many states
such as “enriched in association with motif 1”, “enriched in association with motif 2”,
etc. Biological insight into transcription factors working in conjunction may also motivate
other extensions of the sequence model. As more complex sequence models are developed
one might also consider the use of prior information concerning the TFBS motifs.
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Appendix
The complete sampling scheme for the joint intensity sequence model is given below.
1. Initialize intensity parameters µ1, τ
2
1 , τ
2
0 , and σ
2
a.
2. Initialize sequence parameters Θv and pi.
3. Initialize transition parameters τij.
4. Initialize probe states s1, . . . sP .
5. Sample µ1 ∝
∏P
p=1 fsp(Yp) with MH random walk.
6. Sample τ 21 ∝
∏P
p=1 fsp(Yp) with MH random walk.
7. Sample τ 20 ∝
∏P
p=1 fsp(Yp) with MH random walk.
8. Sample σ2a ∝
∏P
p=1 fsp(Yp) with MH random walk.
9. Compute P (Yp, Xp|sp) = fsp(Yp)psp(Xp) for sp ∈ {0, 1}.
10. Compute gp(0) and gp(1) for p ∈ {1, . . . , n} with Forward Algorithm.
11. Sample Backwards sP , sP−1 . . . s1.
12. Count the number transitions tij where i→ j in s1...P .
13. Sample τij ∼ Beta(tij + δij,
∑
k 6=j tik + δij).
14. Sample Ae,jv for all ne subsequences with algorithm below.
(a) Initialize Ae,jv = 0, nv = 0.
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(b) Let j = Ke the last position in sequence Xe.
(c) Sample Ae,j. ∼ Multinomial(
φe(j−w1)pi1p(Xe[j−w1+1:j]|Θv)
φe(j)
, .., φe(j−wV )piV p(Xe[j−wV +1:j]|Θv)
φe(j)
)
so that Ae,jv = 1 iff the v
th PSWM was sampled Ae,jv = 0 otherwise.
(d) Decrement j by (wv − 1) iff Ae,jv = 1.
(e) Increment nv by 1 iff Ae,jv = 1.
(f) Return to 3 until j = 0.
15. Sample ΘV ∼ PD(B + C).
16. Sample piV ∼ Beta(δ0(1− γ) +
∑v=V −1
v=1 nv, δ0γ + nV ).
17. Sample pi ∼ Dirichlet(n1 + δ1, .., nV −1 + δV −1).
18. Return to 5.
The intensity only sampling scheme would skip steps 2 and steps 14-17, and step 9
would only compute P (Yp|s) = fsp(Yp). The computations of step 9 may be prohibitive
because of the terms psp(Xp) if the number of background motifs V − 1 is large. The
ratio p0(Xp)/p1(XP ) is what is necessary for the computation of gp(sp), and this ratio
may be approximated by reducing the number of background motifs in this step.
The MCMC algorithm was implemented using the C laguage, and the applications
were run on a Linux cluster with dual-CPU 2.8 Ghz Xeon IBM BladeCenter nodes each
with 2.5 GB RAM. The run time for 1,000 iterations of the full model with 10,000 probes
with 1,000 bp sequences is approximately 10 hours.
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